Cancer and Blood Diseases Institute

Publications

Abdullah, S; Leever, G; Langenberg, L; Luebbering, N; Roskin, K; Webster, A; Jodele, S; Davies, SM; Sabulski, DA. Intra- and Inter-Organ Endothelial Cell Differences Contribute to TA-TMA through HMOX1, Hypoxia and Reactive Oxygen Species Signaling. Transplantation and Cellular Therapy. 2024; 30:s142.

Abraham, RS; Basu, A; Heimall, JR; Dunn, E; Yip, A; Kapadia, M; Kapoor, N; Satter, LF; Buckley, R; O'Reilly, R; Cowan, MJ; Puck, J; Dvorak, CC; Haddad, E. Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia. Clinical Immunology. 2024; 261:109942.

Abts, MF; Silva-Carmona, M; Allen, JL; Doherty, EE; Baker, S; MacMillan, ML; Genatassio, A; Lacher, P; Griffin, T; Tekman, M; Edwards, SL; Woods, JC; Davies, SM; Goldfarb, SB. Success and Feasibility of Multiple Breath Washout: Prospective, Multi-Center Results from the Transpire Study. Transplantation and Cellular Therapy. 2024; 30:s142-s143.

Aggarwal, RK; Sidoli, S; Sahu, S; Aluri, S; Vegivinti, C; Verma, D; Gordon-Mitchell, S; Agarwal, B; Verma, T; Starczynowski, DT; LaFave, LM; Cheng, H; Verma, A; Zou, Y. Abstract 1464: Smoking carcinogen-induced inflammation promotes lung carcinogenesis via IRAK4 activation. Cancer Research. 2024; 84:1464.

Akhtar, S; Sagar, K; Roy, A; Hote, MP; Arava, S; Sharma, A. CCR5-mediated homing of regulatory T cells and monocytic-myeloid derived suppressor cells to dysfunctional endothelium contributes to early atherosclerosis. Immunology. 2024; 173:712-729.

Akhtar, S; Sagar, K; Singh, A; Hote, MP; Roy, A; Sharma, A. Inflammation-induced sialin mediates nitrate efflux in dysfunctional endothelium affecting NO bioavailability. Nitric Oxide: Biology and Chemistry. 2024; 146:37-47.

Alavattam, KG; Esparza, JM; Hu, M; Shimada, R; Kohrs, AR; Abe, H; Munakata, Y; Otsuka, K; Yoshimura, S; Kitamura, Y; Kim, J; Andreassen, PR; Ishiguro, KI; Namekawa, SH. ATF7IP2/MCAF2 directs H3K9 methylation and meiotic gene regulation in the male germline. Genes and Development. 2024; 38:115-130.

Al-Samkari, H; Shehata, N; Lang-Robertson, K; Bianchi, P; Glenthøj, A; Sheth, S; Neufeld, EJ; Rees, DC; Chonat, S; Kuo, KH M; Watson, A; Elbard, R; Peereboom, D; Grace, RF. Diagnosis and management of pyruvate kinase deficiency: international expert guidelines. The Lancet Haematology. 2024; 11:e228-e239.

Amarin, JZ; Dulek, DE; Simmons, J; Hayek, H; Chappell, JD; Nochowicz, CH; Kitko, CL; Schuster, JE; Muñoz, FM; Bocchini, CE; Englund, JA; Halasa, NB; Spieker, AJ; Kalams, SA. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients. Blood Advances. 2024; 8:1880-1892.

Ambrose, EE; Samson, A; Aloyce, D; Smart, LR. Understanding Sickle Cell Disease Pain: Perception from Patients, Parents and Healthcare Providers in Northwestern Tanzania. Blood. 2024; 144:5351.

Ambrose, EE; Tomlinson, GA; Ngoya, PS; Stuber, SE; Latham, TS; Makubi, AN; Ware, RE; Smart, LR. Effects of Splenomegaly in Children with Sickle Cell Anemia Treated with Hydroxyurea: Secondary Analysis of the Sphere Trial. Blood. 2024; 144:2495.

Amman, AM; Wolfe, V; Piraino, G; Ziady, A; Zingarelli, B. Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPKα1-Dependent and -Independent Mechanisms. Biomedicines. 2024; 12:2615.

Anandappa, AJ; Trivedi, V; Merlinsky, T; Delgaudio, N; Guzzardi, E; Wooten, A; Starczynowski, D; Bowman, RL; Levine, R; Miles, LA. Codon-Specific Differences in RAS Mutations in AML and Differential Response to Therapeutic Agents. Blood. 2024; 144:2713.

Anderson, AR; Strouse, JJ; Manwani, D; Brandow, AM; Vichinsky, E; Campbell, A; Leavey, PJ; Nero, A; Ibrahim, IF; Field, JJ; Walters, M; Thompson, AA; Tubman, VN; Walters, M. COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study. Blood Advances. 2024; 8:4549-4553.

Andresen, F; He, J; Weller, E; Goldberg, B; Reilly, CR; Nakano, TA; Bertuch, AA; Geddis, AE; Joos, M; Coyne, K; Brundige, K; Loveless, S; Cheng, L; Myers, K; Shimamura, A. Outcomes of Hematopoietic Stem Cell Transplantation for High-Risk Marrow Features without Malignancy in Shwachman-Diamond Syndrome. Blood. 2024; 144:441.

Appiah-Kubi, A; Jacob, SA; Heeney, MM; Piccone, CM; Niss, O; Quinn, CT; Fritch Lilla, SA; Quarmyne, M; Rampersad, A; Remiker, A; Tang, A; Dong, M; McElhinney, K; Tanzer, JR; McGann, PT. Individualized, PK-Guided Dosing of Hydroxyurea for Young Children with Sickle Cell Anemia: Final Results from the Hydroxyurea Optimization through Precision Study (HOPS). Blood. 2024; 144:175.

Arumugam, P; Carey, BC; Wikenheiser-Brokamp, KA; Krischer, J; Wessendarp, M; Shima, K; Chalk, C; Stock, J; Ma, Y; Black, D; Lowe-Daniels, D; Reeves, L; Kaiser, A; Trapnell, BC. A toxicology study of Csf2ra complementation and pulmonary macrophage transplantation therapy of hereditary PAP in mice. Molecular Therapy-Methods & Clinical Development. 2024; 32:101213.

Auld, SC; Sheshadri, A; Alexander-Brett, J; Aschner, Y; Barczak, AK; Basil, MC; Cohen, KA; Cruz, CD; McGroder, C; Restrepo, MI; Staitieh, BS; Stek, C; Sun, J; Evans, SE. Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 2024; 21:1219-1237.

Auletta, JJ; Holter-Chakrabarty, J; Munshi, P; Wall, S; Khera, N; Knutson, J; Gomez-Arteaga, A; Hall, AG; Foster, J; Ruffin, A; Robb, D; Nemecek, E; Rouce, R; Davies, SM. Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 2024; 30:1124-1138.

Avery, R; Jiang, Z; Parida, A; Listernick, R; Liu, G; Ferner, R; Gutmann, D; de Blank, P; Lasky-Zeid, J; Ullrich, N; Reddy, A; Cutter, G; Linguraru, M; Fisher, M. NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY. Neuro-Oncology. 2024; 26:0.

Awuonda, BO; Kiyaga, C; Chirande, L; Franklin, PC; Nnodu, OE; Ambrose, EE; Dogara, LG; Chunda-Liyoka, CM; Segbefia, CI; Coetzer, TL; Ware, RE. Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa: Initial Results of the ASH Consortium on Newborn Screening in Africa (CONSA) Program. Blood. 2024; 144:541.

Aygun, B; Lane, A; Smart, LR; Santos, B; Tshilolo, L; Williams, TN; Olupot-Olupot, P; Stuber, SE; Tomlinson, G; Latham, T; Ware, RE. Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial. The Lancet Haematology. 2024; 11:e425-e435.

Azucenas, CR; Voulgaridou, A; Stewart, M; Ntoumaziou, A; Elgammal, Y; Seu, K; Kalfa, TA. Inducible, Erythroid-Specific Knockout of Codanin-1 in Adult Mice Replicates Congenital Dyserythropoietic Anemia Type-Ia. Blood. 2024; 144:1071.

Azzam, M; Kawtharany, H; Monagle, P; Bercovitz, RS; Hamarsha, Q; Alkhader, A; Abou Zeid, HK; Mansour, R; Patel, P; Tabak, C; Wilson, HP; Woods, G; Zia, A; Mustafa, RA. Anticoagulation Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis. Blood. 2024; 144:1257.

Babic, I; Bryan, N; Cunningham, C; Sampson, A; Starczynowski, D; Nurmemmedov, E. Abstract 3092: MICRO-TAG: A novel fluorescence-based real-time cellular target engagement platform for drug discovery. Cancer Research. 2024; 84:3092.

Bao, C; Zhang, Q; He, C; Zou, H; Xia, Y; Yan, R; Hua, L; Wang, X; Lu, Q; Yao, Z. Neural responses to decision-making in suicide attempters with youth major depressive disorder. NeuroImage-Clinical. 2024; 43:103667.

Bareja, R; Ismail, M; Martin, D; Nayate, A; Yadav, I; Labbad, M; Dullur, P; Garg, S; Tamrazi, B; Salloum, R; Margol, A; Judkins, A; Iyer, S; de Blank, P; Tiwari, P. nnU-Net-based Segmentation of Tumor Subcompartments in Pediatric Medulloblastoma Using Multiparametric MRI: A Multi-institutional Study. Radiology: Artificial Intelligence. 2024; 6:e230115.

Barreyro, L; Sampson, AM; Hueneman, K; Choi, K; Christie, S; Ramesh, V; Wyder, M; Wang, D; Pujato, M; Greis, KD; Huang, G; Starczynowski, DT. Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML. iScience. 2024; 27:109809.

Bartlett, AL; Wagner, JE; Jones, B; Wells, S; Sabulski, A; Fuller, C; Davies, SM. Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia. Blood Advances. 2024; 8:3027-3037.

Bedolla, A; Wegman, E; Weed, M; Stevens, MK; Ware, K; Paranjpe, A; Alkhimovitch, A; Ifergan, I; Taranov, A; Peter, JD; McClain, L; Roskin, KM; Greig, NH; Luo, Y. Adult microglial TGFβ1 is required for microglia homeostasis via an autocrine mechanism to maintain cognitive function in mice. Nature Communications. 2024; 15:5306.

Bender, JD; Damodharan, S; Capitini, CM; Moskop, A; Toner, K; Vatsayan, A; Talano, JA; Baggott, C; Schiff, D; Katsanis, E; Modi, AJ; Quigg, TC; Raikar, SS; Schultz, LM; Pommert, L. Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Advances. 2024; 8:4164-4168.

Bender, JD; Pillay-Smiley, N; Hill, GD; de Blank, P; Hummel, TR; Weiss, BD; Kumar, A; Zang, H; Ollberding, NJ; Ryan, TD. Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center Study. JACC: CardioOncology. 2024; 6:794-796.

Benedetti, DJ; Renfro, LA; Tfirn, I; Daw, NC; Kalapurakal, JA; Ehrlich, PF; Khanna, G; Perlman, E; Warwick, A; Gow, KW; Fernandez, CV; Geller, JI; Mullen, EA; Dome, JS. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 2024; 130:2361-2371.

Benedetti, DJ; Varela, CR; Renfro, LA; Tornwall, B; Dix, DB; Ehrlich, PF; Glick, RD; Kalapurakal, J; Perlman, E; Gratias, E; Grundy, P; Fernandez, CV; Dome, JS; Mullen, EA. Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5. Cancer. 2024; 130:947-961.

Benjamin, ES B; Vinod, E; Illangeswaran, RS S; Rajamani, BM; Vidhyadharan, RT; Bagchi, A; Maity, A; Mohan, A; Parasuraman, G; Amirtham, SM; Abraham, A; Velayudhan, SR; Balasubramanian, P. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs. Cellular Signalling. 2024; 116:111067.

Benson, TW; Pike, MM; Spuzzillo, A; Hicks, SM; Ali, S; Pham, M; Mix, DS; Brunner, SI; Wadding-Lee, C; Conrad, KA; Gardiner, EE; Mackman, N; Cameron, SJ; Owens, AP. Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target. Blood. 2024; 144:1663-1678.

Beslow, LA; Krings, T; Kim, H; Hetts, SW; Lawton, MT; Ratjen, F; Whitehead, KJ; Gossage, JR; McCulloch, CE; Clancy, M; Vethanayagam, D; Weinsheimer, S; White, AJ; Wilcox, P. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Pediatric Neurology. 2024; 155:120-125.

Beslow, LA; Vossough, A; Kim, H; Nelson, J; Lawton, MT; Pollak, J; Lin, DD M; Ratjen, F; Hammill, AM; Hetts, SW; Weinsheimer, S; White, AJ; Wilcox, P; Wilcox, P. Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia. Child's Nervous System. 2024; 40:2101-2108.

Beslow, LA; White, AJ; Krings, T; Hammill, AM; Lang, SS; Baba, A; Clancy, MS; Olitsky, SE; Hetts, SW. Current Practice: Rationale for Screening Children with Hereditary Hemorrhagic Telangiectasia for Brain Vascular Malformations. American Journal of Neuroradiology. 2024; 45:1177-1184.

Betensky, M; Mosha, M; Tarango, C; Verma, A; Bhat, R; Kucine, NE; Nakano, T; Nakar, C; Woods, G; Amankwah, E; Brandão, LR; Schulman, S; Goldenberg, NA. Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial. Blood Advances. 2024; 8:5790-5795.

Bhatt, NS; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Yingling, S; Edgar, C; Browning, A; Lee, CJ. Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Blood. 2024; 144:4921.

Bhatt, NS; Meyer, CL; Mau, LW; Auletta, JJ; Baker, KS; Broglie, L; Carpenter, PA; Choi, SW; Dandoy, CE; Devine, S; Phelan, R. Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States. Bone Marrow Transplantation. 2024; 59:653-659.

Bielamowicz, K; Dimitrion, P; Abla, O; Bomken, S; Campbell, P; Collin, M; Degar, B; Diamond, EL; Eckstein, OS; El-Mallawany, N; Shaw, PH; Wistinghausen, B; Rodriguez-Galindo, C; Allen, CE. Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer. 2024; 130:2416-2439.

Blake, C; Widmeyer, K; DAquila, K; Mochizuki, A; Smolarek, TA; Pillay-Smiley, N; Kim, SY. 14q22.3 duplication including OTX2 in a girl with medulloblastoma: A case report with literature review. American Journal of Medical Genetics, Part A. 2024; 194:e63604.

Böhm, S; Wustrau, K; Pachlopnik Schmid, J; Prader, S; Ahlmann, M; Yacobovich, J; Beier, R; Speckmann, C; Behnisch, W; Ifversen, M; Lindemans, C; Henter, JI; Lehmberg, K; Ehl, S. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation. Blood. 2024; 143:872-881.

Borst, AJ; Eng, W; Griffin, M; Ricci, KW; Engel, E; Adams, DM; Dayneka, J; Cohen-Cutler, SJ; Andreoli, SM; Wu, MD; Teitelbaum, M; Zong, Z; Li, Y; Jeng, MR. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatric Blood and Cancer. 2024; 71:e30779.

Bouju, A; Nusse, R; Wu, PV. A primer on the pleiotropic endocrine fibroblast growth factor FGF19/FGF15. Differentiation; Research in Biological Diversity. 2024; 140:100816.

Bouley, SJ; Grassetti, AV; Allaway, RJ; Wood, MD; Hou, HW; Burdon Dasbach, IR; Seibel, W; Wu, J; Gerber, SA; Dragnev, KH; Walker, JA; Sanchez, Y. Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of Cell Science. 2024; 137:jcs262343.

Bowman, RL; Dunbar, AJ; Mishra, T; Xiao, W; Waarts, MR; Maestre, IF; Eisman, SE; Cai, L; Mowla, S; Shah, N; Miles, LA; Ferrell, PB; Trowbridge, JJ; Levine, RL. In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy. Cancer Cell. 2024; 42:1955-1969.e7.

Brandewie, K; Lorts, A; Luchtman-Jones, L; Gao, Z; Geer, B; Villa, C; Perry, T. Impact of inflammation and steroids on anti-coagulation in children supported on a ventricular assist device. Journal of Artificial Organs. 2024; 27:368-374.

Cacciotti, C; Lenzen, A; Self, C; Pillay-Smiley, N. QOL-06. RECURRENCE PATTERNS AND SURVEILLANCE IMAGING IN PEDIATRIC BRAIN TUMOR SURVIVORS. Neuro-Oncology. 2024; 26:0.

Cacciotti, C; Lenzen, A; Self, C; Pillay-Smiley, N. Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors. Journal of Pediatric Hematology/Oncology. 2024; 46:e227-e232.

Caisova, V; Rivero-Hinojosa, S; Tardito, S; Zhang, H; Lu, I; Chintala, N; Mochizuki, A; Pei, Y; Murad, N; Sneiderman, C; Kohanbash, G; Yang, J; Rood, B. MDB-45. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA. Neuro-Oncology. 2024; 26:0.

Campbell, P; Riazzi, A; Spitznagel, E; Schulte, M; Frias, O; Daugherty, M; Vanderbrink, B; DeFoor, W; Minevich, E; Reddy, P; Streich-Tilles, T; Burns, K; Strine, A. Time to therapy and safety of testicular tissue cryopreservation in children undergoing gonadotoxic treatment or hematopoietic stem cell transplant. Journal of Pediatric Urology. 2024; 20:747.e1-747.e7.

Canaud, G; López-Gutiérrez, JC; Hammill, AM; Weibel, L; Niglis, S; Paul, M; Papadimitriou, A; Wroclawska, M; Adams, DM. Epik-P2: A Phase 2 Study of Alpelisib (ALP) in Pediatric and Adult Patients (pts) with PIK3CA -Related Overgrowth Spectrum (PROS). Blood. 2024; 144:5512.

Cansanay, RD; Erker, C; Ratterman, E; Schlosser, MP; Ronsley, R; Cacciotti, C; Hukin, J; Cheng, S; Pillay-Smiley, N; Magimairajan, V; Rutkowski, S; Lassaletta, A; Bouffet, E; Lafay-Cousin, L. MDB-09. WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH. Neuro-Oncology. 2024; 26:0.

Carreras, E; Diaz-Ricart, M; Jodele, S; Penack, O; Vasu, S. Early Complications of Endothelial Origin. The EBMT Handbook. : Springer Nature; Springer Nature; 2024.

Carter-Febres, M; Fenchel, M; Pomales, J; Tarango, C; Mullins, ES. Hemoglobin concentration and body mass index are determinants of plasma von Willebrand factor and factor VIII levels. Thrombosis Research. 2024; 240:109061.

Chang, YH; Yamamoto, K; Fujino, T; Wang, TW; Sugimoto, E; Zhang, W; Yabushita, T; Suzaki, K; Pietsch, EC; Weir, BA; Enomoto, Y; Imai, Y; Kitamura, T; Goyama, S. SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation. Cell Reports. 2024; 43:114536.

Chavana, AN; Taylor, ZL; DeGroote, N; Lindsay, HB; Sauer, HE; Mason, EJ; Schafer, ES; Miller, TP; Castellino, SM; Pommert, L; O'Brien, MM; Ramsey, LB; Bernhardt, MB; Brown, AL. Toxicity profile of high-dose methotrexate in young children with central nervous system tumors. Pediatric Blood and Cancer. 2024; 71:e31213.

Chawla, EM; Schuler, CL; Barnhardt, EW; Herbst, LA; Sarkissian, A; McNeal-Trice, K; Newmeyer, A; Perry, M; Poynter, SE; Lannon, C. Integrating education for clinical practice change. The Clinical Teacher. 2024; 21:e13753.

Chen, N; Sakabe, M; Xin, M. Abstract We146: CHD8 is Essential for Postnatal Heart Function through Preserving Mitochondrial Integrity. Circulation Research. 2024; 135:awe146.

Chi, M; Vandenheuvel, K; Malik, P. Splenic Ossification in Sickle Cell Anemia Mice. Blood. 2024; 144:5283.

Chi, SN; Lazow, M; Salloum, R; Lane, A; Hargrave, D; Witt, O; de Blank, P; Leary, SE S; Gorsi, H; Pierson, C; Yang, E; Mikael, L; Jones, DT W; Fouladi, M. TRLS-09. CONNECT1903: A PILOT AND SURGICAL STUDY OF LAROTRECTINIB FOR TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED HGG WITH NTRK FUSION (NCT04655404). Neuro-Oncology. 2024; 26:0.

Chiang, S; Murguia-Favela, L; Wright, N; Steele, M; Seroogy, C; Blanchard-Rohner, G; Shrikhande, A; Wilson, J; Yang, L; Owsley, E; Derfalvi, B; Brager, R; Jordan, M; Marwaha, A. 68 LRBA dysfunction: a new diagnostic entity caused by biallelic LRBA missense variants results in reduced CTLA-4 expression and autoimmunity. Clinical Immunology. 2024; 262:110010.

Chiang, SC C; Covill, LE; Tesi, B; Campbell, TM; Schlums, H; Nejati-Zendegani, J; Mördrup, K; Wood, S; Theorell, J; Sekine, T; Horne, AC; Henter, JI; Meeths, M; Bryceson, YT. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis. Blood. 2024; 144:873-887.

Chokshi, SM; Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Uncommon BK polyomaviruses detected in allogeneic hematopoietic cell transplant recipients. Microbiology Resource Announcements. 2024; 13.

Chokshi, SM; Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Uncommon BK polyomaviruses detected in allogeneic hematopoietic cell transplant recipients. Editor, Matthijnssens J. Microbiology Resource Announcements. 2024; 13:e0000524.

Clark, D; Abdullah, S; Sabulski, DA; Towe, C; Langenberg, L; Davies, SM; Koo, DJ; Myers, KC. An in Vitro Patient-Derived Model of Bronchiolitis Obliterans Syndrome Yields New Insight into Steroid Sensitivity and Resistance. Transplantation and Cellular Therapy. 2024; 30:s252.

Clark, J; Wunderlich, M; Chen, J; Starczynowski, D; Lee, L. Abstract A017: IGF2BP1 is essential for ETO2/GLIS2 leukemogenesis via stabilization of primitive myeloid transcriptional programs. Molecular Cancer Therapeutics. 2024; 23:a017.

Cline, H; Wei, Z; Groeneveld, DJ; Hix, JM L; Xu, X; Flick, MJ; Palumbo, JS; Poole, LG; Dockendorff, C; Griffin, JH; Luyendyk, JP. Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity. Journal of Thrombosis and Haemostasis. 2024; 22:3191-3198.

Cohen, CT; Tarango, C; Powers, JM. Emicizumab use in infancy: A survey of United States Pediatric Hemophilia Treatment Center Medical Directors. Haemophilia. 2024; 30:848-851.

Cook, E; Dong, M; Chiang, SC C; Luedeke, D; Lake, KE; Hoerth, C; Deavy, M; Setchell, KD R; Zhao, J; Punt, N; Davies, SM; Marsh, RA; Mehta, P; Khandelwal, P. Ruxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2024; 30:528.e1-528.e12.

Coppola, T; Hughes, H; Finch, PT; Hess, JA; Wu, S; Prada, CE; Miethke, AG; Zhang, W; Kalfa, TA. Case report: Childhood erythrocytosis due to hypermanganesemia caused by homozygous SLC30A10 mutation. 2024; 3:1331485.

Correia, D; Indelicato, DJ; Paulino, AC; Ermoian, R; Mihalcik, S; Perkins, SM; Hill-Kayser, C; Mangona, VS; Lee, J; Chang, JH C; Bajaj, BV M; Allison, KW; Perry, A; Yock, TI. Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry. Practical Radiation Oncology. 2024; 14:e507-e514.

Costa, E; Isgrò, A; de Montalembert, M; Leufkens, HG M; Ware, RE; De Franceschi, L. Successes and pitfalls in orphan drug development for sickle cell disease. Blood Advances. 2024; 8:2455-2465.

Cournoyer, E; Ferrell, J; Sharp, S; Ray, A; Jordan, M; Dandoy, C; Grimley, M; Roy, S; Lorsbach, R; Merrow, AC; Nelson, A; Bartlett, A; Picarsic, J; Kumar, A. Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders. Haematologica: the hematology journal. 2024; 109:1137-1148.

Cui, S; Chen, T; Xin, D; Chen, F; Zhong, X; Dong, C; Chen, X; Chen, H; Zhou, W; Lin, Y; Lu, QR. Zinc-Finger Protein ZFP488 Regulates the Timing of Oligodendrocyte Myelination and Remyelination. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2024; 44:e0141242024.

Culver-Cochran, AE; Hassan, A; Hueneman, K; Choi, K; Ma, A; VanCauwenbergh, B; O’Brien, E; Wunderlich, M; Perentesis, JP; Starczynowski, DT. Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis. Nature Communications. 2024; 15:9189.

D’Alessandro, PR; McGrady, ME; Nagata, JM; Norris, RE; Pressey, JG. Body Image Concerns in Adolescent and Young Adult Oncology Patients within Six Months of Upfront Diagnosis. Journal of Adolescent and Young Adult Oncology. 2024; 13:792-798.

Dandoy, CE; Adams, J; Artz, A; Bredeson, C; Dahi, PB; Dodd, T; Jaglowski, S; Lehmann, L; LeMaistre, CF; Mian, A; Sorror, M; Steinberg, A; Viswabandya, A; Howard, DS. In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy. Transplantation and Cellular Therapy. 2024; 30:942-954.

Dandoy, CE; Hyman, D; Ayers, D; Cheung, A; Kennedy, AR; Messali, A; Pérez-Simón, JA. Survival Outcomes in Adult and Pediatric Patients Who Experienced Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Blood. 2024; 144:7286.

Dashti, HS; Wang, YM; Knauert, MP. Feeding critically ill patients at the right time of day. Critical Care (UK). 2024; 28:206.

Daugherty, EC; Zhang, Y; Xiao, Z; Mascia, AE; Sertorio, M; Woo, J; McCann, C; Russell, KJ; Sharma, RA; Khuntia, D; Bradley, JD; Simone, CB; Breneman, JC; Perentesis, JP. FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach. Radiation Oncology. 2024; 19:34.

de Blank, PM K; Lange, KR; Xing, M; Mirzaei Salehabadi, S; Srivastava, D; Brinkman, TM; Ness, KK; Oeffinger, KC; Neglia, J; Krull, KR; Leisenring, W; Armstrong, GT; Okcu, MF; Bowers, DC. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study. Nature Cancer. 2024; 5:590-600.

de Oliveira, MH S; Abosamak, MF; Henry, BM; Benoit, SW; Lippi, G; Previdelli, I. Longitudinal serum chloride as a marker for poor prognosis in severely ill COVID-19 patients: A joint model approach. Brazilian Journal of Biometrics. 2024; 42:88-99.

Desai, PB; Karve, AS; Zawit, M; Arora, P; Dave, N; Awosika, J; Li, N; Fuhrman, B; Medvedovic, M; Sallans, L; Zuccarello, M; Chaudhary, R; Sengupta, S; Wise-Draper, TM. A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas. Clinical Cancer Research. 2024; 30:2068-2077.

Doig, M; Kwok, Y; Lee, J; Macewan, I; Mangona, V; Laack, N; Wolden, S; Perentesis, J; Allison, K; Galloto, S; Gorayski, P; Le, H; Bezak, E; Yock, T. O114 / #164 DOSE TO ORGANS AT RISK IMPACTS HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOR CHILDREN WITH BRAIN TUMORS. International Journal of Particle Therapy. 2024; 12:100227.

Dorn, L; Engel, E; Perry, T; Luchtman-Jones, L. Bivalirudin Monitoring By Dilute Thrombin Time Is Cost-Efficient in Pediatric ECMO Patients. Blood. 2024; 144:5018.

Dourson, AJ; Fadaka, AO; Warshak, AM; Paranjpe, A; Weinhaus, B; Queme, LF; Hofmann, MC; Evans, HM; Donmez, OA; Forney, C; Weirauch, MT; Kottyan, LC; Lucas, D; Deepe, GS; Jankowski, MP. Macrophage memories of early-life injury drive neonatal nociceptive priming. Cell Reports. 2024; 43:114129.

Drucker, M; Dhingra, D; Wunderlich, M; Perentesis, J; Starczynowski, D; Bowman, RL; Miles, LA. Single-Cell Multi-Omic Analysis of KMT2A-Rearranged Pediatric Acute Leukemia Clonal Evolution. Blood. 2024; 144:66.

Du, Y; Liu, J; Lin, R; Chattun, MR; Gong, W; Hua, L; Tang, H; Han, Y; Lu, Q; Yao, Z. The mediating role of family functioning between childhood trauma and depression severity in major depressive disorder and bipolar disorder. Journal of Affective Disorders. 2024; 365:443-450.

Duan, X; Evelyn, CR; Biesiada, J; Johnson, JF; Seibel, WL; Meller, J; Zheng, Y. Abstract 5912: Rational design of a small-molecule inhibitor targeting the allosteric site of sos1 in oncogenic k-ras pancreatic cancer. Cancer Research. 2024; 84:5912.

Eissa, H; Thakar, MS; Shah, AJ; Logan, BR; Griffith, LM; Dong, H; Parrott, RE; O'Reilly, RJ; Dara, J; Kapoor, N; Haddad, E; Buckley, RH; Cowan, MJ; Heimall, J. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. Journal of Allergy and Clinical Immunology. 2024; 153:287-296.

Elgamal, OA; Fobare, S; Vibhute, S; Mehmood, A; Vroom, DC; Johnson, ML; Stearns, B; Lerma, JR; Truxall, J; Stahl, E; Hilinski, G; Bennett, CE; Hertlein, E; Byrd, JC. Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia. JCI insight. 2024; 9:e173646.

Elgarten, CW; Grimley, M. Prophylactic VSTs: a promising start but still work to do. Blood Advances. 2024; 8:4738-4739.

Engel, ER; Le Cras, TD; Ricci, KW. How we use angiopoietin-2 in the diagnosis and management of vascular anomalies. Pediatric Blood and Cancer. 2024; 71:e30921.

Engel, ER; Perry, T; Block, M; Palumbo, JS; Lorts, A; Luchtman-Jones, L. Bivalirudin Monitoring in Pediatric Ventricular Assist Device and Extracorporeal Membrane Oxygenation: Analysis of Single-Center Retrospective Cohort Data 2018-2022. Pediatric Critical Care Medicine. 2024; 25:e328-e337.

Engel, ER; Wusik, K; Bright, P; Vadivelu, S; Taylor, JM; Hammill, A. Prevalence and Predictors of Hereditary Hemorrhagic Telangiectasia and Capillary-Malformation Arteriovenous Malformation Syndrome Among Children with Neurovascular Malformations. The Journal of Pediatrics. 2024; 264:113761.

Evageliou, N; Renfro, LA; Geller, J; Perlman, E; Kalapurakal, J; Paulino, A; Dix, D; Eklund, MJ; Murphy, AJ; Romao, RL P; Vallance, K; Fernandez, CV; Dome, JS; Mullen, EA. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532. Cancer. 2024; 130:792-802.

Fang, Z; Duan, C; Wang, S; Fu, L; Yang, P; Yu, T; Deel, MD; Lau, LM S; Ma, X; Ni, X; Su, Y. Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: a case report and literature review. Translational Pediatrics. 2024; 13:178-191.

Fangusaro, J; Onar-Thomas, A; Poussaint, TY; Lensing, S; Ligon, AH; Lindeman, N; Banerjee, A; Kilburn, L; Lenzen, A; Pillay-Smiley, N; Jones, DT W; Stewart, CF; Fouladi, M; Dunkel, IJ. LGG-05. REPORT ON PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-029B, A PROSPECTIVE PHASE 2 CLINICAL TRIAL OF SELUMETINIB IN TREATING YOUNG PATIENTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA: NEW RESULTS ON STRATA 2, 5, AND 6 WITH UPDATED LONG-TERM SURVIVAL OUTCOMES ON STRATA 1, 3, AND 4. Neuro-Oncology. 2024; 26:0.

Farr, R; Bonn, J; Khorki, ME; Goldstein, S; Bondoc, A; Tiao, G; Somers, K; Geller, JI; Schuh, MP. Single-Center Case Series of Congenital Anomalies of the Kidney and Urinary Tract and Hepatoblastoma. Journal of the American Society of Nephrology : JASN. 2024; 35:10.1681/asn.20241j3dwf9j.

Fertitta, L; Bergqvist, C; Sarin, KY; Plotkin, SR; Moertel, C; Petersen, AK; Cannon, A; Berman, Y; Pichard, DC; Röhl, C; Jannic, A; Ezzedine, K; Wolkenstein, P; Response Evaluation in Neurofibromatosis and Schwa, . A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. British Journal of Dermatology. 2024; 190:216-225.

Fidler, A; Chang, E; Dandoy, C; Beebe, D; Smith, D; Dye, T; Wang, YM. 0820 Challenges to Pediatric Patients Sleeping Well in the Hospital: Environmental and Practice Considerations. Sleep. 2024; 47:a351-a352.

Filuta, AL; Amezcua, P; Ruff, BP; Biagini, JM; Kroner, J; He, H; Brandt, EB; Martin, LJ; Palumbo, JS; Khurana Hershey, GK; Sherenian, MG. The key roles of thrombin and fibrinogen in human infant and mice atopic dermatitis models. Allergy: European Journal of Allergy and Clinical Immunology. 2024; 79:239-242.

Fisher, MJ; de Blank, P; Listernick, R; Liu, G; Ferner, R; Gutmann, D; Lasky-Zeid, J; Ullrich, N; Heidary, G; Bornhorst, M; Esbenshade, A; Donahue, S; Cutter, G; Avery, R. NFS-21. DEMOGRAPHIC, CLINICAL AND IMAGING CHARACTERISTICS OF NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1: RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY. Neuro-Oncology. 2024; 26:0.

Fobare, S; Elgamal, OA; Wunderlich, M; Stahl, E; Mehmood, A; Furby, C; Lerma, JR; Sesterhenn, TM; Pan, J; Rai, J; Johnson, ML; Rai, SN; Byrd, JC; Hertlein, E. Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid Leukemia. Cancers. 2024; 16:569.

Forrest, J; Steinway, C; Shaw, E; Jan, S; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Boruchov, D; Niss, O; Andemariam, B; Smith-Whitley, K; Trachtenberg, S; Belton, T. Community Health Worker Engagement with Adolescents and Young Adults with Sickle Cell Disease: Findings from the Comets Study. Blood. 2024; 144:617.

Garcia-Manero, G; Platzbecker, U; Lim, K; Nowakowski, G; Abdel-Wahab, O; Kantarjian, H; Verma, A; Starczynowski, DT. Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer. 2024; 3:1339870.

Gatterdam, C; Emberesh, S; Elgammal, Y; Lutzko, C; Blanc, L; Cancelas, J; Kalfa, TA; Seu, K. The Dominant Negative Acting VPS4AE228Q Mutation Causes Dyserythropoiesis in Human iPSC-Derived Erythroblast Cultures That Phenocopies Cimdag Syndrome-Associated Anemia. Blood. 2024; 144:2458.

Gatts, J; Chandra, S; Krishnan, D; Ricci, K. Medical Management of Nonmalignant Vascular Tumors of the Head and Neck: Part 1. Oral and Maxillofacial Surgery Clinics of North America. 2024; 36:103-113.

Gatts, J; Chandra, SR; Ricci, K. Medical Management and Therapeutic Updates on Vascular Anomalies of the Head and Neck: Part 2. Oral and Maxillofacial Surgery Clinics of North America. 2024; 36:115-123.

Ghosh, A; Li, H; Towbin, AJ; Turpin, BK; Trout, AT. Histogram Analysis of Apparent Diffusion Coefficient Maps Provides Genotypic and Pretreatment Phenotypic Information in Pediatric and Young Adult Rhabdomyosarcoma. Academic Radiology. 2024; 31:2550-2561.

Gibson, NM; Amaral, S; Hsu, JY; Nguyen, N; Haney, M; Heimbruch, KE; Sabulski, A; Davidow, KA; Lind, K; Scanlon, S; Alva, H; Bailey, LC; Olson, TS; Kwiatkowski, JL. Defining the Impacts of Iron Overload in Children Receiving Hematopoietic Stem Cell Transplantation for Non-Malignant Hematologic Disorders: A Multicenter Analysis. Blood. 2024; 144:1064.

Glaser, K; Schepers, EJ; Zwolshen, HM; Lake, CM; Timchenko, NA; Karns, RA; Cairo, S; Geller, JI; Tiao, GM; Bondoc, AJ. EZH2 is a key component of hepatoblastoma tumor cell growth. Pediatric Blood and Cancer. 2024; 71:e30774.

Goldstein, JA; Renfro, LA; Jennings, LJ; Mullen, EA; Geller, J; Vallance, K; Fernandez, CV; Perlman, EJ. BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2. Archives of Pathology and Laboratory Medicine. 2024; 148:e362-e366.

Gorfinkel, L; Qayed, M; Bratrude, B; Betz, K; Hebert, K; Choi, SW; Davis, J; Duncan, C; Giller, RH; Grimley, MS; Horan, JT; Langston, A; Kean, L; Watkins, B. Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘). Blood. 2024; 144:3516.

Gorfinkel, L; Raghunandan, S; Watkins, B; Hebert, K; Neuberg, DS; Bratrude, B; Betz, K; Yu, A; Choi, SW; Davis, J; Horan, JT; Langston, A; Kean, LS; Qayed, M. Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD. Bone Marrow Transplantation. 2024; 59:680-687.

Govindarajah, V; Sakabe, M; Good, S; Solomon, M; Arasu, A; Chen, N; Zhang, X; Grimes, HL; Kendler, A; Xin, M; Reynaud, D. Gestational diabetes in mice induces hematopoietic memory that affects the long-term health of the offspring. The Journal of Clinical Investigation. 2024; 134:e169730.

Green, A; Rubinstein, JD; Grimley, M; Pfeiffer, T. Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation. Journal of the Pediatric Infectious Diseases Society. 2024; 13:S49-S57.

Grimley, M; Marón, GM; Gomez, CA; Prasad, VK; Dara, J; Lion, T; Papanicolaou, GA; Fukushima, K; Wynn, RF; Boeckh, MJ. Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection. Transplantation and Cellular Therapy. 2024; 30:s89.

Grom, AA; Canna, SW; Abu-Arja, RF; Sinha, R; Peixoto, L; Cannizzaro, E; Chandrakasan, S; Driest, K; Marsh, R; Neven, B; Schulert, G; Silva, JM F; Wall, D; Zeilhofer, U. Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe. Pediatric Rheumatology Online Journal. 2024; 21:86.

Grunebaum, E; Arnold, DE; Logan, B; Parikh, S; Marsh, RA; Griffith, LM; Mallhi, K; Chellapandian, D; Lim, SS; Deal, CL; Torgerson, TR; Malech, HL; Kang, EM; Leiding, JW. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium study. Journal of Allergy and Clinical Immunology. 2024; 153:1423-1431.e2.

Gulati, R; Fleifil, Y; Jennings, K; Bondoc, A; Tiao, G; Geller, J; Timchenko, L; Timchenko, N. Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers. Cancers. 2024; 16:2300.

Gulati, R; Lutz, M; Hanlon, M; Cast, A; Karns, R; Geller, J; Bondoc, A; Tiao, G; Timchenko, L; Timchenko, NA. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma. Hepatology Communications. 2024; 8:e0369.

Hambrick, HR; Fei, L; Pavia, K; Kaplan, J; Mizuno, T; Tang, P; Schuler, E; Benoit, S; Girdwood, ST. Cystatin C Outperforms Creatinine in Predicting Cefepime Clearance in Pediatric Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 2024; 30:614.e1-614.e11.

Hambrick, HR; Pavia, K; Tang Girdwood, S; Lazear, D; Taylor, JM; Benoit, S. Cefepime-Associated Neurotoxicity in a Pediatric Patient With Stage V Chronic Kidney Disease. Journal of Pharmacy Practice. 2024; 37:243-247.

Hammill, AM; Boscolo, E. Capillary malformations. The Journal of Clinical Investigation. 2024; 134:e172842.

Harms, FL; Rexach, JE; Efthymiou, S; Aynekin, B; Per, H; Güleç, A; Nampoothiri, S; Sampaio, H; Sachdev, R; Stoeva, R; Chard, M; Klassen, M; Pries, M; Kutsche, K. Loss of TBC1D2B causes a progressive neurological disorder with gingival overgrowth. European Journal of Human Genetics. 2024; 32:558-566.

Hasson, DC; Mohan, S; Rose, JE; Merrill, KA; Goldstein, SL; Benoit, SW; Varnell, CD. Ionized Magnesium Correlates With Total Blood Magnesium in Pediatric Patients Following Kidney Transplant. Annals of Laboratory Medicine. 2024; 44:21-28.

Hegde, S; Akbar, H; Wellendorf, AM; Nestheide, S; Johnson, JF; Zhao, X; Setchell, KD; Zheng, Y; Cancelas, JA. Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold-stored platelets. Blood. 2024; 144:1732-1746.

Henter, JI; Sieni, E; Eriksson, J; Bergsten, E; Hed Myrberg, I; Canna, SW; Coniglio, ML; Cron, RQ; Kernan, KF; Kumar, AR; Bottai, M; Bryceson, YT; Horne, AC; Jordan, MB. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Blood. 2024; 144:2308-2318.

Hofstetter, KS; Haas, PM; Kuntz, JP; Zheng, Y; Fuhrmann, S. Loss of Cdc42 causes abnormal optic cup morphogenesis and microphthalmia in mouse. Frontiers in Cellular Neuroscience. 2024; 18:1474010.

Hoyt, SB; Finocchio, CJ; Croll, E; Tawa, GJ; Li, H; Ma, L; Li, K; Liu, L; Li, R; Zhang, X; Culver-Cochran, AE; Rosenbaum, JS; Starczynowski, DT; Thomas, CJ. Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia. ACS Medicinal Chemistry Letters. 2024; 15:1843-1851.

Huang, G; Li, Z; Liu, X; Guan, M; Zhou, S; Zhong, X; Zheng, T; Xin, D; Gu, X; Mu, D; Guo, Y; Zhang, L; Zhang, L; Lu, QR; He, X. DOR activation in mature oligodendrocytes regulates α-ketoglutarate metabolism leading to enhanced remyelination in aged mice. Nature Neuroscience. 2024; 27:2073-2085.

Huber, J; Dexheimer, J; Vaughn, L; Wall, J; O'Connor, G; Badia, P; Davies, SM; Dandoy, DC E. HSCT Patient and Family Education Concept Identification. Transplantation and Cellular Therapy. 2024; 30:s344-s345.

Hudda, Z; Flannery, A; Dilhoff, P; Webster, K; Jacobs, J; Strong, S; Detzel, J; Davies, SM; Khandelwal, P. Chronic Graft Versus Host Disease Adversely Affects School Performance and Quality of Life in Children and Young Adults. Transplantation and Cellular Therapy. 2024; 30:s43-s44.

Hudda, Z; Flannery, A; Teusink-Cross, A; Davies, SM; Khandelwal, P. Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD. Bone Marrow Transplantation. 2024; 59:425-427.

Huynh, NP T; Osipovitch, M; Foti, R; Bates, J; Mansky, B; Cano, JC; Benraiss, A; Zhao, C; Lu, QR; Goldman, SA. Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia. Brain: a journal of neurology. 2024; 147:3099-3112.

Iacobas, I; Hammill, AM. Hereditary hemorrhagic telangiectasia - pediatric review. Current Opinion in Pediatrics. 2024; 36:592-598.

Ikegami, S; Amanda, D; Heyenbruch, D; Leemhuis, T; Lutzko, C; Alquist, CR; Cancelas, J. CMV SEROSTATUS IS MOST IMPORTANT TO SELECT DONORS OF MONONUCLEAR CELL PRODUCTS AIMED TO THE GENERATION OF ANTI-CMV VIRUS-SPECIFIC T CELL (VSTS) PRODUCTS. Cytotherapy (Informa). 2024; 26:e20-e21.

Ismail, M; Um, H; Salloum, R; de Blank, P; Tiwari, P. MDB-42. RADIOMIC TEXTURAL AND MORPHOLOGICAL-BASED FEATURES TO RISK-STRATIFY PEDIATRIC MEDULLOBLASTOMA PATIENTS. Neuro-Oncology. 2024; 26:0.

Ismail, M; Um, H; Salloum, R; de Blank, P; Tiwari, P. MDB-40. DEFORMATION-HETEROGENEITY RADIOMIC MEASURES TO RISK-STRATIFY PEDIATRIC MEDULLOBLASTOMA PATIENTS: A PRELIMINARY ANALYSIS. Neuro-Oncology. 2024; 26:0.

Ismail, M; Um, H; Salloum, R; Hollnagel, F; Ahmed, R; de Blank, P; Tiwari, P. A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study. Cancers. 2024; 16:2248.

Jan, S; Steinway, C; Belton, T; Shults, J; Bennett, L; Griffis, H; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Boruchov, D; Barakat, L; Andemariam, B; Rubin, D; Smith-Whitley, K. Community Health Worker and Mobile Health Programs to Help Young Adults with Sickle Cell Disease Transition to Using Adult Healthcare Services – the Comets Study; Results from Patient-Reported Outcomes at 6 Months. Blood. 2024; 144:1066.

Jebanesan, DZ P; Illangeswaran, RS S; Rajamani, BM; Vidhyadharan, RT; Das, S; Bijukumar, NK; Balakrishnan, B; Mathews, V; Velayudhan, SR; Balasubramanian, P. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia. Annals of Hematology. 2024; 103:1919-1929.

Jodele, S; Dandoy, CE; Aguayo-Hiraldo, P; Lane, A; Teusink-Cross, A; Sabulski, A; Mizuno, K; Laskin, BL; Freedman, J; Davies, SM. A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA. Blood. 2024; 143:1112-1123.

Kahn, J; Brazauskas, R; Bo-Subait, S; Buchbinder, D; Hamilton, BK; Schoemans, H; Abraham, AA; Agrawal, V; Auletta, JJ; Badawy, SM; Williams, KM; Vrooman, LM; Satwani, P; Phelan, R. Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study. The Lancet Child and Adolescent Health. 2024; 8:740-750.

Kawtharany, H; Azzam, M; Monagle, P; Bercovitz, RS; Alkhader, A; Hamarsha, Q; Abou Zeid, HK; Mansour, R; Tabak, C; Patel, P; Wilson, HP; Woods, G; Zia, A; Mustafa, RA. Thrombolytic Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis. Blood. 2024; 144:2633.

Khandelwal, P; Langenberg, L; Luebbering, N; Lake, KE; Butcher, A; Bota, K; Ramos, KN; Taggart, C; Choe, H; Vasu, S; Watanabe-Chailland, M; Haslam, DB; Lane, A; Davies, SM. A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults. Blood. 2024; 143:1181-1192.

Khandelwal, P; Pommert, L. Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients. 2024; 21.

Kharnaf, M; Abplanalp, WA; Young, C; Sprague, C; Rosenfeldt, L; Smith, R; Wang, D; Palumbo, JS; Morales, DL S. Unmasking the Impact of Oxygenator-Induced Hypocapnia on Blood Lactate in Veno-Arterial Extracorporeal Membrane Oxygenation. ASAIO Journal. 2024; 70:795-802.

Kharnaf, M; Zafar, F; Hogue, S; Rosenfeldt, L; Cantrell, RL; Sharma, BK; Pearson, A; Sprague, C; Leino, D; Abplanalp, WA; Morales, D; Tweddell, J; Qualls, JE; Palumbo, JS. Factor XII promotes the thromboinflammatory response in a rat model of venoarterial extracorporeal membrane oxygenation. Journal of Thoracic and Cardiovascular Surgery. 2024; 168:e37-e53.

Khoury, R; Grimley, MS; Nelson, AS; Leemhuis, T; Cancelas, JA; Cook, E; Wang, YZ; Heyenbruch, D; Bollard, CM; Keller, MD; Hanley, PJ; Lutzko, C; Pham, G; Davies, SM; Rubinstein, JD. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 2024; 24:1634-1643.

Kiang, KM; Ahad, L; Zhong, X; Lu, QR. Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer. Trends in Cell Biology. 2024; 34:566-577.

Kim, TO; Geris, JM; Flanagan, JM; Grace, RF; Lambert, MP; O’Farrell, C; Rose, MJ; Shimano, KA; Niss, O; Neunert, C; Neufeld, EJ; Despotovic, JM; Scheurer, ME; Grimes, AB. Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Advances. 2024; 8:5529-5538.

Kimbrell, B; McKenney, KD; Yeom, S; Iannotti, I; Day, A; Harmon, K; Sebold, A; Smegal, L; Kaplan, K; Daisy, C; Pinto, A; Hammill, A; Moses, MA; Comi, A. Longitudinal prospective study of Sturge–Weber syndrome urine angiogenic factors and neurological outcome. 2024; 2:120-134.

Kiyaga, C; Ambrose, EE; Awuonda, BO; Chirande, L; Chunda-Liyoka, CM; Dogara, LG; Franklin, PC; Nnodu, OE; Segbefia, CI; Ware, RE; Coetzer, TL. Building Capacity in Sub-Saharan Africa to Address Sickle Cell Disease: The Consortium on Newborn Screening in Africa (CONSA). Blood. 2024; 144:520.

Klages, KL; Schwartz, LE; Crabtree, EJ S; Brokamp, C; Rasnick, E; Dandoy, CE; Davies, SM; Pai, AL H. Social determinants of health predict health outcomes following pediatric allogeneic hematopoietic stem cell transplant. Pediatric Blood and Cancer. 2024; 71:e30892.

Klaver, YL B; Hoogeman, MS; Lu, QR; Amos, RA; Hawkins, MA; Simone, CB. Requirements and Study Design for the Next Proton Flash Clinical Trials: An International Multidisciplinary Delphi Consensus. International Journal of Radiation: Oncology - Biology - Physics. 2024; 120:s108-s109.

Knapp, J; Ermoian, RP; Indelicato, DJ; Lee, JY; Perentesis, JP; Perkins, SM; Laack, NN; Chang, J; MacEwan, I; Wolden, SL; Wang, D; Aridgides, PD; Yock, TI. Outcomes Following Radiation Therapy (RT) for Embryonal Tumor with Multilayered Rosettes (ETMR): Results from the Pediatric Proton/Photon Consortium Registry (PPCR). International Journal of Radiation: Oncology - Biology - Physics. 2024; 120:e697.

Kocoshis, TS; Kalfa, TA; Miethke, AG; Balistreri, WF; Seu, KG; Slaughter, CG; Singh, R; Mullen, M; Kocoshis, SA. Red cell abnormalities characterized by ektacytometry in children with cholestasis. Pediatric Research. 2024; 95:1035-1040.

Kögl, T; Chang, HF; Staniek, J; Chiang, SC C; Thoulass, G; Lao, J; Weißert, K; Dettmer-Monaco, V; Geiger, K; Manna, PT; Bryceson, YT; Ehl, S; Aichele, P; Ammann, S. Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect. The Journal of Experimental Medicine. 2024; 221:e20221122.

Koo, DJ; Hornung, L; Sabulski, DA; Mehta, PA; Howell, JC; Davies, SM; Myers, KC. Longitudinal Bone Health in Patients with Fanconi Anemia and Other Major Inherited Bone Marrow Failure Syndromes. Transplantation and Cellular Therapy. 2024; 30:s291.

Koo, DJ; Huber, J; Badia, P; Dunseath, C; O'Connor, G; Davies, SM; Dandoy, DC E. Invasive Fungal Infections Are Rare in Pediatric and Young Adult Autologous Hematopoietic Stem Cell Transplant Patients. Transplantation and Cellular Therapy. 2024; 30:s122.

Koo, J; Hord, J; Gilliam, C; Rae, ML; Staubach, K; Nowacki, K; Lyren, A; Coffey, M; Dandoy, CE. Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review. Pediatric Hematology-Oncology (Informa). 2024; 41:432-448.

Koo, J; Howell, JC; Hornung, L; Sabulski, A; Mehta, PA; Davies, SM; Myers, KC. Infrequent fractures and resilient bone mineral density: bone health in patients with Fanconi anemia. Haematologica: the hematology journal. 2024; 109:3435-3438.

Koo, J; Huber, J; Badia, P; Dunseath, C; O'Connor, G; Davies, SM; Dandoy, CE. Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood and Cancer. 2024; 71:e31336.

Koo, J; Langenberg, L; Luebbering, N; Strecker, L; Abdullah, S; Carusone, E; Deavy, M; Hoerth, C; Miller, G; Turner, D; Ziady, AG; Myers, KC; Jodele, S; Davies, SM. Ceramides Are Elevated in Transplant-Associated Thrombotic Microangiopathy in Hematopoietic Stem Cell Transplant Recipients and Are a Druggable Target for Prophylaxis. Transplantation and Cellular Therapy. 2024; 30:s17-s18.

Koschmann, C; Al-Holou, WN; Alonso, MM; Anastas, J; Bandopadhayay, P; Barron, T; Becher, O; Cartaxo, R; Castro, MG; Chung, C; Yadav, VN; Zhang, X; Zhang, Q; Venneti, S. A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell. 2024; 42:1-5.

Kotch, C; de Blank, P; Gutmann, DH; Fisher, MJ. Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions. Child's Nervous System. 2024; 40:3241-3250.

Kotch, C; Solomon, DA; Wallace, K; de Blank, PM; Li, Y; Mbonglou, F; Reddy, AT; Gutmann, DH; Piotrowski, AF; Fisher, MJ. NFS-08. CLINICAL AND MOLECULAR FEATURES OF HIGH-GRADE GLIOMA IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1: A PRELIMINARY ANALYSIS. Neuro-Oncology. 2024; 26:0.

Kusne, Y; Badar, T; Lasho, T; Ferrer, A; Mangaonkar, AA; Finke, C; Marando, L; Foran, JM; Al-Kali, A; Alkhateeb, HB; Chlon, T; Patnaik, MM. Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired BM failure syndromes. Leukemia Research: clinical and laboratory studies. 2024; 145:107561.

Langenberg, L; Davies, SM; Koo, DJ. Hypusine Modulation in Hematopoietic Stem Cell Transplant Recipients: A Novel Insight into GI Gvhd Mechanisms. Transplantation and Cellular Therapy. 2024; 30:s250.

Laranjeira, AB A; Kong, T; Snyder, SC; Fulbright, MC; Fisher, DA C; Starczynowski, DT; Oh, ST. In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood. 2024; 143:2414-2424.

Latham, TS; Czabanowska, K; Babich, S; Yego, F; Ware, RE. Stroke Training, Research, and Education Toward Capacity with Hydroxyurea (STRETCH). Blood. 2024; 144:2242.

Lazow, M; Baxter, P; Kumar, SS; Mohamad, M; Mackay, A; Stanek, J; Rodriguez, D; Palmer, J; Leach, J; Mikael, L; Jones, C; Mardis, E; Fouladi, M; Drissi, R. PATH-13. MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT). Neuro-Oncology. 2024; 26:viii180.

LeBlanc, FR; Breese, EH; Burns, KC; Chang, EK; Jones, LQ M; Lee, L; Mizukawa, B; Norris, RE; O'Brien, MM; Phillips, CL; Perentesis, JP; Rubinstein, J; Pommert, L. Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British Journal of Haematology. 2024; 205:1055-1066.

LeBlanc, FR; Grier, DD; Myers, KC; Shimamura, A; Pommert, L. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. 2024; 71:e31137.

Lee, BJ; Arter, Z; Doh, J; Griffin, SP; Vittayawacharin, P; Atallah, S; Shieh, KR; Tran, M; Jodele, S; Kongtim, P; Ciurea, SO. Eculizumab for Shiga-toxin-induced hemolytic uremic syndrome in adults with neurological involvement. ejHaem. 2024; 5:548-553.

Lee, CJ; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Yingling, S; Edgar, C; Browning, A; Bhatt, N. Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Blood. 2024; 144:2170.

Lee, D; Abu-Shihab, Y; Nicolet, D; Mrózek, K; Routbort, M; Patel, KP; Walker, CJ; Buss, J; Stiff, A; Laganson, A; Blachly, JS; Loghavi, S; Eisfeld, A; Miles, LA. BRAF-Mutated Acute Myeloid Leukemia (AML) Represents a Prognostically Poor Subgroup Enriched for Myelodysplasia-Related Subtypes and Distinct from Other RAS Pathway Mutant AML. Blood. 2024; 144:2921.

Lee, SC-E S; Pyo, AH A; Mohammadi, H; Zhang, J; Dvorkin-Gheva, A; Malbeteau, L; Chung, S; Khan, S; Ciudad, MT; Rondeau, V; Culp-Hill, R; D'Alessandro, A; Jones, CL; Koritzinsky, M. Cysteamine dioxygenase (ADO) governs cancer cell mitochondrial redox homeostasis through proline metabolism. Science Advances. 2024; 10:eadq0355.

Leever, G; Segev, N; Hornung, L; Myers, KC; Davies, SM; Howell, JC; Langenberg, L; Luebbering, N; Sabulski, DA. A Standardized Approach to Bone Health Screening in Pediatric HSCT and the Study of Bone Health Biomarkers. Transplantation and Cellular Therapy. 2024; 30:s348-s349.

Lendrum, EC; Smart, LR; Vukovic, AA. Pancytopenia in the Emergency Department. The Journal of Pediatrics. 2024; 272:114111.

Lenen, A; Waanders, AJ; Bazzi, L; Zhang, H; Lai, J; Plant-Fox, AS; Cluster, A; Crawford, J; Cohen, K; Dickens, D; Fangusaro, J; Lulla, R; Goldman, S; Pillay-Smiley, N. LGG-37. A PHASE III STUDY COMPARING TWO CARBOPLATIN CONTAINING REGIMENS FOR CHILDREN AND YOUNG ADULTS WITH PREVIOUSLY UNTREATED LOW-GRADE GLIOMA. Neuro-Oncology. 2024; 26:0.

Leon, MD; Otto, WR; Danziger-Isakov, L; Kumar, A; Huang, FS. Infectious Diseases Evaluation of the Child With Suspected Hemophagocytic Lymphohistiocytosis. Journal of the Pediatric Infectious Diseases Society. 2024; 13:220-227.

Li, J; Hashimoto, M; Pan, M; Zeng, H; Andreassen, PR; Huang, G. Loss of Cpt1a Results in Elevated Mitochondrial Reactive Oxygen Species from Glucose-Fueled Mitochondrial Oxidative Phosphorylation and Defective Hematopoietic Stem Cells. Blood. 2024; 144:4035.

Lin, Y; Ramelot, TA; Senyuz, S; Gursoy, A; Jang, H; Nussinov, R; Keskin, O; Zheng, Y. Tumor-derived RHOA mutants interact with effectors in the GDP-bound state. Nature Communications. 2024; 15:7176.

Lin, Y; Zhao, X; Liou, B; Fannin, V; Zhang, W; Setchell, KD R; Wang, X; Pan, D; Grabowski, GA; Liu, CJ; Sun, Y. Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease. Human Molecular Genetics. 2024; 33:1771-1788.

Little, K; Zhu, Z; Gbotosho, O; Malik, P. Blockade of Angiotensin II Signaling Ameliorates Cardiac Fibrosis and Improves Diastolic Dysfunction in Mice with Sickle Cell Anemia. Blood. 2024; 144:2480.

Liu, X; Xin, DE; Zhong, X; Zhao, C; Li, Z; Zhang, L; Dourson, AJ; Lee, L; Mishra, S; Bayat, AE; Jankowski, MP; Barton, SK; He, X; Lu, QR. Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. Cell. 2024; 187:2465-2484.e22.

Loo, BW; Verginadis, II; Sørensen, BS; Mascia, AE; Perentesis, JP; Koong, AC; Schüler, E; Rankin, EB; Maxim, PG; Limoli, CL; Vozenin, MC. Navigating the Critical Translational Questions for Implementing FLASH in the Clinic. Seminars in Radiation Oncology. 2024; 34:351-364.

Lovvorn, HN; Renfro, LA; Benedetti, DJ; Kotagal, M; Phelps, HM; Ehrlich, PF; Lo, AC; Sandberg, JK; Treece, AL; Gow, KW; Fernandez, CV; Dome, JS; Geller, JI; Mullen, EA. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2. Journal of the American College of Surgeons. 2024; 238:733-749.

Luebbering, N; Abdullah, S; Roskin, K; Webster, A; Blackard, JT; Odegard, E; Laskin, B; Seif, AE; Jodele, S; Davies, SM; Sabulski, DA. Single Cell Rnaseq Identifies Chemokine Responses to BK Polyomavirus Infection and Novel Contribution of MAIT Cells. Transplantation and Cellular Therapy. 2024; 30:s84.

Lulla, RR; Buxton, A; Krailo, MD; Lazow, MA; Boue, DR; Leach, JL; Lin, T; Geller, JI; Kumar, SS; Nikiforova, MN; Gajjar, A; Drissi, R; Pollack, IF; Fouladi, M. Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study. Neuro-Oncology Advances. 2024; 6:vdae035.

Lv, X; Lu, Q; Yang, J. Methodological issues in the evaluation of cold snare endoscopic mucosal resection for colon polyps. Endoscopy. 2024; 56:79.

Manning, ER; Duan, Q; Taylor, S; Ray, S; Corley, AM S; Michael, J; Gillette, R; Unaka, N; Hartley, D; Beck, AF; Riley, C; Sandoval, L; Shook, L; Steller, J. Development of a multimodal geomarker pipeline to assess the impact of social, economic, and environmental factors on pediatric health outcomes. Journal of the American Medical Informatics Association : JAMIA. 2024; 31:1471-1478.

Marsh, RA. Salvage Therapy and Allogeneic Hematopoietic Cell Transplantation for the Severe Cytokine Storm Syndrome of Hemophagocytic Lymphohistiocytosis. Advances in Experimental Medicine and Biology. 2024; 1448:611-622.

Mascia, A; McCauley, S; Speth, J; Nunez, SA; Boivin, G; Vilalta, M; Sharma, RA; Perentesis, JP; Sertorio, M. Impact of Multiple Beams on the FLASH Effect in Soft Tissue and Skin in Mice. International Journal of Radiation: Oncology - Biology - Physics. 2024; 118:253-261.

Matsui, S; Ri, C; Bolanos, LC; Choi, K; Shibamiya, A; Ishii, A; Takaishi, K; Oshima-Hasegawa, N; Tsukamoto, S; Takeda, Y; Yokote, K; Starczynowski, DT; Sakaida, E; Muto, T. Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia. 2024; 38:1032-1045.

McCall, D; Abuasab, T; Rodriguez-Sevilla, JJ; Mohamed, SF; Patnaik, A; Devireddy, K; Arani, N; Sheikh, I; Jamshidi, R; Gibson, A; Issa, G; Cuglievan, B; Kantarjian, H; Garcia-Manero, G. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leukemia Research: clinical and laboratory studies. 2024; 144:107563.

McDonnell, J; Cousins, K; Younger, ME M; Lane, A; Abolhassani, H; Abraham, RS; Al-Tamemi, S; Aldave-Becerra, JC; Al-Faris, EH; Alfaro-Murillo, A; Lim, XR; Lopes, JP; López, AL; Tarquini, L. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. Journal of Clinical Immunology. 2024; 44:86.

McGrady, ME; Ignjatovic, V; Jones, S; Bruce, A; Goldenberg, NA; Rizzi, M; Thornburg, CD; Todd, KE; Luchtman-Jones, L. Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 2024; 22:2081-2092.

McGrady, ME; Ketterl, TG; Webster, RT; Schwartz, LE; Brock, MY; Szulczewski, L; Burke, M; Hommel, KA; Pai, AL H; Mara, CA; Steele, AC; Regan, GG; Norris, RE. Feasibility pilot trial of a tailored medication adherence-promotion intervention for adolescents and young adults with cancer: Study design and protocol. Contemporary Clinical Trials. 2024; 139:107483.

McLaurin, WS; Francisco, BJ; Hooker, KJ; Sheshashayee, N; Khan, MT F; Triana, RR; Rao, MB; Pressey, JG; Krishnan, DG. Antiresorptive and anti-angiogenic drug therapy in the pediatric population with reference to medication-related osteonecrosis of the jaw. International Journal of Oral and Maxillofacial Surgery. 2024; 53:496-502.

Meijer, AJ M; Diepstraten, FA; Ansari, M; Bouffet, E; Bleyer, A; Fresneau, B; Geller, JI; Huitema, AD R; Kogner, P; Maibach, R; Veal, GJ; Sullivan, M; van den Heuvel-Eibrink, MM; Brock, PR. Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature. Journal of Clinical Oncology. 2024; 42:2219-2232.

Mersich, I; Congrove, S; Horchar, M; Caceres, R; Desai, J; Desai, P; Sallans, L; Haines, J; Menon, R; Stevenson, C; Tavassoli, A; D’Alessandro, A; Phoenix, T; Dasgupta, B. DIPG-17. DYSREGULATED PURINE METABOLISM IN A LETHAL CHILDHOOD BRAINSTEM TUMOR REVEALS NEW TREATMENT STRATEGIES WITH OLD DRUGS. Neuro-Oncology. 2024; 26:0.

Meyer, AP; Barnett, CL; Myers, K; Siskind, CE; Moscarello, T; Logan, R; Roggenbuck, J; Rich, KA. Neuromuscular and cardiovascular phenotypes in paediatric titinopathies: a multisite retrospective study. Journal of medical genetics. 2024; 61:356-362.

Miranda, MA; Tsalatsanis, A; Trotter, JR; Arnold, DE; Squire, JD; Kidd, S; Parikh, S; Marsh, RA; Griffith, LM; Mallhi, K; Malech, HL; Kang, EM; Morton, FB; Leiding, JW. High symptom burden in female X-linked chronic granulomatous disease carriers. Clinical Immunology. 2024; 268:110364.

Mochizuki, AY; Hummel, TR; Cripe, T; Fouladi, M; Pollack, IF; Mitchell, D; Young Poussaint, T; Onar-Thomas, A; Pillay-Smiley, N; DeWire-Schottmiller, M; Stevenson, CB. Intratumoral/Peritumoral Herpes Simplex Virus-1 Mutant HSV1716 in Pediatric Patients with Refractory or Recurrent High-Grade Gliomas: A Report of the Pediatric Brain Tumor Consortium. 2024; 5:1.

Mochizuki, AY; Hummel, TR; Cripe, T; Fouladi, M; Stevenson, CB; Pollack, I; Mitchell, D; Poussaint, TY; Onar-Thomas, A; DeWire-Schottmiller, M; Pillay-Smiley, N. IMMU-17. A PHASE I STUDY OF INTRATUMORAL/PERITUMORAL HERPES SIMPLEX VIRUS-1 MUTANT HSV1716 IN PATIENTS WITH REFRACTORY OF RECURRENT HIGH-GRADE GLIOMAS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY. Neuro-Oncology. 2024; 26:0.

Mochizuki, AY; Nagaraj, CB; Depoorter, D; Schieffer, KM; Kim, SY. Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome. American Journal of Medical Genetics, Part A. 2024; 194:e63788.

Morrison, A; Myers, K; Streich-Tilles, T. 5. Human Papillomavirus Vaccination Uptake in Adolescent Survivors of Bone Marrow Transplant. Journal of Pediatric and Adolescent Gynecology. 2024; 37:224.

Mosley, C; Farrell, CB; Quinn, CT; Shook, LM. A Mixed-Methods Evaluation of a Project ECHO Program for the Evidence-Based Management of Sickle Cell Disease. International Journal of Environmental Research and Public Health. 2024; 21:530.

Mueller, S; Fangusaro, J; Thomas, AO; Jacques, TS; Bandopadhayay, P; de Blank, P; Packer, RJ; Fouladi, M; van Meeteren, AS; Jones, D; Robison, NJ; Partanen, M; Fisher, MJ; Witt, O. Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group. Neuro-Oncology. 2024; 26:407-416.

Mullins, TL K; Mullins, ES. Thrombotic risk associated with gender-affirming hormone therapy. Journal of Thrombosis and Haemostasis. 2024; 22:2129-2139.

Murphy, AJ; Brzezinski, J; Renfro, LA; Tornwall, B; Malek, MM; Benedetti, DJ; Cost, NG; Smith, EA; Aldrink, J; Romao, RL P; Paulino, AC; Lo, AC; Geller, JI; Ehrlich, PF. Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study. International Journal of Cancer. 2024; 155:1824-1831.

Murphy, BN; Hood, AM; Hildenbrand, AK; Shook, LM; Quinn, CT; Smoot, E; Sil, S; Crosby, LE. Location, Location(s), Location(s+): Moving from Acute to Chronic Pain in SCD Pain in School-Age Children. Blood. 2024; 144:5360.

Murphy, BN; Keenan-Pfeiffer, ME; Lane, A; Crosby, LE; Walsh, KE. Feasibility of a clinic-based, multicomponent hydroxyurea adherence intervention for adolescents and young adults with sickle cell disease. Pediatric Blood and Cancer. 2024; 71:e31144.

Myers, B; Brayer, K; Paez-Beltran, L; Keith, M; Suzuki, H; New, J; Anderson, R; Lo, Y; Mertz, C; Kollipara, R; Borromeo, M; Lu, R; Bachoo, R; Johnson, J; Vue, TY. CNSC-46. GLIOBLASTOMA INITIATION, MIGRATION, AND CELL TYPES ARE REGULATED BY CORE BHLH TRANSCRIPTION FACTORS ASCL1 AND OLIG2. Neuro-Oncology. 2024; 26:viii51.

Myers, BL; Brayer, KJ; Paez-Beltran, LE; Villicana, E; Keith, MS; Suzuki, H; Newville, J; Anderson, RH; Lo, Y; Mertz, CM; Lu, QR; Bachoo, RM; Johnson, JE; Vue, TY. Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration. Nature Communications. 2024; 15:10363.

Myers, K; He, J; Goldberg, B; Reilly, CR; Wan, Y; Zhu, X; Cesaro, S; Cipolli, M; Bertuch, AA; O'Farrell, C; Cheng, L; Weller, E; Donadieu, J; Shimamura, A. Incidence of Myeloid Malignancy in Shwachman-Diamond Syndrome: An International Cohort Study. Blood. 2024; 144:2703.

Namazzi, R; Bond, C; Conroy, AL; Datta, D; Tagoola, A; Goings, MJ; Jang, JH; Ware, RE; Opoka, R; John, CC. Hydroxyurea reduces infections in children with sickle cell anemia in Uganda. Blood. 2024; 143:1425-1428.

Neidemire-Colley, L; Khanal, S; Braunreiter, KM; Gao, Y; Kumar, R; Snyder, KJ; Weber, MA; Surana, S; Toirov, O; Karunasiri, M; Kararoudi, MN; Choe, HK; Garzon, R; Ranganathan, P. CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model. Blood Advances. 2024; 8:947-958.

Niss, O; Fenchel, M; Kingsley, E; Latham, TS; Malik, P; Quinn, CT. Underutilization of Disease-Modifying Therapies in Sickle Cell Disease: A Real-World Analysis from the ASH Research Collaborative Data Hub. Blood. 2024; 144:2312.

Niss, O; Morin, C; Lang, SM; Alsaied, T; Tasset, M; Malik, P; Quinn, CT. Longitudinal Assessment of Myocardial Fibrosis in Sickle Cell Disease. Blood. 2024; 144:799.

Ntoumaziou, A; Nguyen, D; Elgammal, Y; Husami, A; Zhang, W; Weaver, KD; Kasten, JL; Grier, DD; Zheng, Y; Lutzko, C; Risinger, M; Frayne, J; Seu, K; Kalfa, TA. Loss of ATG5 in Humans Causes Syndromic Congenital Dyserythropoietic Anemia with Impaired Mitophagy in Late Stages of Terminal Erythropoiesis. Blood. 2024; 144:1084.

Oatman, N; Gawali, MV; Congrove, S; Cáceres, R; Sukumaran, A; Gupta, N; Murugesan, N; Arora, P; Subramanian, S; Choi, K; Desai, P; D'Alessandro, A; Komurov, K; Dasgupta, B. A Multimodal Drug-Diet-Immunotherapy Combination Restrains Melanoma Progression and Metastasis. Cancer Research. 2024; 84:2333-2351.

Odia, Y; Koschmann, C; Vitanza, NA; De Blank, P; Aguilera, D; Allen, J; Daghistani, D; Hall, M; Khatib, Z; Kline, C; McGovern, SL; Khatua, S; Zaky, W; Gardner, SL. Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-Oncology. 2024; 26:S155-S164.

O'Hare, P; Cooney, T; De Blank, P; Gutmann, DH; Kieran, M; Milde, T; Fangusaro, J; Fisher, M; Avula, S; Packer, R; Ashley, DM; Ertl-Wagner, BB; Tabori, U; Hargrave, DR. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition. Neuro-Oncology. 2024; 26:1357-1366.

O'Neill, AF; Trobaugh-Lotrario, A; Geller, JI; Hiyama, E; Watanabe, K; Aerts, I; Fresneau, B; Toutain, F; Sullivan, MJ; Katzenstein, HM; Morland, B; Branchereau, S; Zsiros, J; Maibach, R; Ansari, M. The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution. EClinicalMedicine. 2024; 69:102446.

Ottesen, EW; Seo, J; Luo, D; Singh, NN; Singh, RN. A super minigene with a short promoter and truncated introns recapitulates essential features of transcription and splicing regulation of the SMN1 and SMN2 genes. Nucleic Acids Research (NAR). 2024; 52:3547-3571.

Ottesen, EW; Singh, NN; Seo, J; Singh, RN. U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes. Frontiers in Neuroscience. 2024; 18:1412893.

Pabinger, I; Ayash-Rashkovsky, M; Escobar, M; Konkle, BA; Mingot-Castellano, ME; Mullins, ES; Negrier, C; Pan, L; Rajavel, K; Yan, B; Chapin, J. Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia. Gene Therapy (Basingstoke). 2024; 31:273-284.

Pai, AA; Mohanan, E; Panetta, JC; Kulkarni, UP; Illangeswaran, RS S; Balakrishnan, B; Jayaraman, A; Edison, ES; Lakshmi, KM; Devasia, AJ; Srivastava, A; Mathews, V; Standing, JF; Balasubramanian, P. Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation. Clinical Pharmacology and Therapeutics. 2024; 115:116-125.

Pandurangi, S; Malik, A; Owens, J; Valencia, CA; Miethke, AG; Marsh, R; Chiang, S; Yang, L; Hopkin, R; Kasten, J; Huggins, J; Gutierrez Sanchez, LH; Castro-Rojas, C; Alquaraish, M. Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis. Journal of Hepatology. 2024; 80:e26-e28.

Papanicolaou, GA; Chen, M; He, N; Martens, MJ; Kim, S; Batista, MV; Bhatt, NS; Hematti, P; Hill, JA; Liu, H; Perales, MA; Chemaly, RF; Riches, M; Ustun, C. Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis. Transplantation and Cellular Therapy. 2024; 30:114.e1-114.e16.

Papini, C; Mirzaei, SS; Xing, M; Olsson, IT; de Blank, PM K; Lange, KR; Salloum, R; Srivastava, D; Leisenring, WM; Howell, RM; Oeffinger, KC; Robison, LL; Armstrong, GT; Krull, KR; Brinkman, TM. Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma. Journal of the National Cancer Institute. 2024; 116:288-298.

Pastura, P; McDaniel, CG; Alharbi, S; Fox, D; Coleman, B; Malik, P; Adams, DM; Le Cras, TD. NRASQ61R mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model. Pediatric Blood and Cancer. 2024; 71:e31032.

Patritti-Cram, J; Rahrmann, EP; Rizvi, TA; Scheffer, KC; Phoenix, TN; Largaespada, DA; Ratner, N. NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14. iScience. 2024; 27:110294.

Paudel, SN; Hutzen, BJ; Miller, KE; Garfinkle, EA R; Chen, CY; Wang, PY; Glaspell, AM; Currier, MA; Ringwalt, EM; Boon, L; Ratner, N; Dodd, RD; Cassady, KA; Cripe, TP. Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors. Frontiers in Immunology. 2024; 15:1384623.

Perotti, D; Williams, RD; Wegert, J; Brzezinski, J; Maschietto, M; Ciceri, S; Gisselsson, D; Gadd, S; Walz, AL; Furtwaengler, R; Perlman, EJ; Gessler, M; Huff, V; Pritchard-Jones, K. Hallmark discoveries in the biology of Wilms tumour. Nature Reviews Urology. 2024; 21:158-180.

Perrino, MR; Ahmari, N; Hall, A; Jackson, M; Na, Y; Pundavela, J; Szabo, S; Woodruff, TM; Dombi, E; Kim, MO; Köhl, J; Wu, J; Ratner, N. C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis. Life Science Alliance. 2024; 7:e202302229.

Pommert, L. Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?. 2024; 21.

Potter, A; Wikenheiser-Brokamp, K; Hildeman, D; Sharma, N; Gu, M; Patel, K; Qureshi, M; Khan, MM; Wallace, C; Ziady, A; Hayes, D. (601) Decoding T Cell Clonal Dynamics in Acute Lung Rejection. The Journal of Heart and Lung Transplantation. 2024; 43:s293.

Power-Hays, A; Dong, M; Punt, N; Mizuno, T; Smart, LR; Vinks, AA; Ware, RE. Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia. Clinical Pharmacology and Therapeutics. 2024; 116:670-677.

Power-Hays, A; McElhinney, KE; Latham, TS; Williams, TN; Mochamah, G; Olupot-Olupot, P; Paasi, G; Reid, ME; Rankine-Mullings, A; Opoka, R; John, CC; McGann, PT; Quinn, CT; Stuber, SE; Ware, RE. Hydroxyurea Pharmacokinetics in Children with Sickle Cell Anemia: Comparison of Global Cohorts. Blood. 2024; 144:542.

Power-Hays, A; Tomlinson, GA; Tshilolo, L; Santos, B; Williams, TN; Olupot-Olupot, P; Smart, LR; Aygun, B; Lane, A; Stuber, SE; Latham, T; Ware, RE. Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American Journal of Hematology. 2024; 99:625-632.

Primeaux, S; Stutzman, SE; Malone, K; Schaefer, B; Bhat, R; Khan, O; Torres, M; Kumar, R; Rajpurkar, M; Bernstein, J; Martinelli, M; Corley, S; Sida, D; Zia, A. The Fuvid Study: Functional Characterization of Children with Pulmonary Embolism in a Prospective Multicenter Cohort Study. Blood. 2024; 144:5555.

Prus, K; Evans, A; Matatiyo, A; Mapurisa, G; Nonganonga, M; Mutafya, T; Banda, K; Misiri, M; Kamija, M; Mzikamanda, RR; Westmoreland, KD; Ware, RE. Low Rate of Red Blood Cell Alloimmunization Among Transfused Children with Sickle Cell Anemia in Malawi without Pre-Transfusion Screening or Antigen Matching. Blood. 2024; 144:4032.

Pundavela, J; Dinglasan, SA; Touvron, M; Hummel, SA; Hu, L; Rizvi, TA; Choi, K; Hildeman, DA; Ratner, N. Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance. Science Advances. 2024; 10:eado6342.

Qiao, J; Tao, S; Sun, Y; Shi, J; Chen, Y; Tian, S; Yao, Z; Lu, Q. The Effects of Variation in the GABAA Receptor Gene on Anxious Depression are Mediated by the Functional Connectivity Between the Amygdala and Middle Frontal Gyrus. Neuropsychiatric Disease and Treatment. 2024; 20:1781-1796.

Ramos, KN; Lake, KE; Hoerth, C; Langenberg, L; Luebbering, N; Haslam, D; Newburg, D; Morrow, AL; Ollberding, NJ; Denson, LA; Watanabe-Chailland, M; Romick-Rosendale, L; Davies, SM; Khandelwal, P. Administration of Human Milk Oligosaccharide (2′-fucosyllactose) Reduces Dysbiosis and Increases Short Chain Fatty Acids in Children and Young Adults Following HSCT: A Prospective, Single-Center Study. Transplantation and Cellular Therapy. 2024; 30:s16.

Ramos, KN; Langenberg, L; Strecker, L; Luebbering, N; Davies, SM; Khandelwal, P. Lower Levels of the Vitamin A Transporter Serum Amyloid A1 (SAA1) Are Associated with Improved HSCT Outcomes in Children and Young Adults. Transplantation and Cellular Therapy. 2024; 30:s134-s135.

Ramos, KN; Leino, D; Luebbering, N; Grimley, M; Badia, P; Davies, SM; Khandelwal, P. Successful Use of Teduglutide As Adjunctive Therapy in the Management of GI GvHD in Children and Young Adults: A Single Center Case Series. Transplantation and Cellular Therapy. 2024; 30:s136.

Ramos, KN; Leino, D; Luebbering, N; Grimley, MS; Badia, P; Davies, SM; Khandelwal, P. Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults. Transplantation and Cellular Therapy. 2024; 30:454.e1-454.e6.

Rangarajan, H; Chellapandian, D; Atshan, R; Wooahn, K; Sharma, A; Schultz, KR; Mehta, PA; Phillips, CL; Broglie, L; Satwani, P. Impact of Extramedullary Disease on the Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Acute Myeloid Leukemia - a CIBMTR Analysis. Blood. 2024; 144:2412.

Raskin, SI; de Blank, PM K; Billups, CA; Li, Y; Olson, JM; Leary, SE S. MDB-86. ISOTRETINOIN HAS NO EFFECT ON EVENT FREE SURVIVAL ACROSS HIGH-RISK MEDULLOBLASTOMA MOLECULAR SUBGROUPS WHEN ADDED TO MAINTENANCE CHEMOTHERAPY: A SECONDARY ANALYSIS OF THE CHILDREN’S ONCOLOGY GROUP ACNS0332 DATA. Neuro-Oncology. 2024; 26:0.

Raut, NG R; Maile, LA; Oswalt, LM; Mitxelena, I; Adlakha, A; Sprague, KL; Rupert, AR; Bokros, L; Hofmann, MC; Patritti-Cram, J; Rizvi, TA; Queme, LF; Choi, K; Ratner, N; Jankowski, MP. Schwann cells modulate nociception in neurofibromatosis 1. JCI insight. 2024; 9:e171275.

Rayes, A; Logan, B; Liu, X; Dara, J; Buckley, RH; Oved, JH; Kapoor, N; Kapadia, M; Chandra, S; Martinez, C; Heimall, JR; Haddad, E; Pai, S; Dvorak, CC. Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc. Transplantation and Cellular Therapy. 2024; 30:s92-s93.

Reed, HD; Do, H; Weller, EA; Harris, MH; Farrar, JE; Lau, BW; Pommert, L; Gamper, C; Atkinson, I; Coyne, K; Cheng, L; Malsch, M; Myers, K; Shimamura, A. Lymphoid Malignancies in Shwachman-Diamond Syndrome. Blood. 2024; 144:5707.

Reel, SM; Siegel, RM; Pillay Smiley, N. Pediatric Oncology and Obesity: An Introduction for General Pediatricians. Clinical Pediatrics. 2024; 63:589-593.

Reynaud, D. GM-CSF brings (good) memories. Blood. 2024; 143:2683-2684.

Riabov, V; Xu, Q; Schmitt, N; Streuer, A; Ge, G; Bolanos, L; Wunderlich, M; Jann, JC; Wein, A; Altrock, E; Steiner, L; Jawhar, M; Hofmann, WK; Nowak, D. ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. Haematologica: the hematology journal. 2024; 109:1426-1438.

Ricci, K. Medical Therapeutics for the Treatment of Vascular Anomalies: Part 3. Oral and Maxillofacial Surgery Clinics of North America. 2024; 36:125-136.

Romao, RL P; Aldrink, JH; Renfro, LA; Mullen, EA; Murphy, AJ; Brzezinski, J; Malek, MM; Benedetti, DJ; Cost, NG; Smith, E; Paulino, A; Kalapurakal, JA; Geller, JI; Ehrlich, PF. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatric Blood and Cancer. 2024; 71:e30981.

Rondeau, V; Berman, JM; Ling, T; O’Brien, C; Culp-Hill, R; Reisz, JA; Wunderlich, M; Chueh, Y; Jiménez-Camacho, KE; Sexton, C; Minden, MD; Raught, B; D’Alessandro, A; Jones, CL. Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models. Science Translational Medicine. 2024; 16:eadn1285.

Rotz, SJ; Hamilton, BK; Wei, W; Ahmed, I; Winston, SA; Ballard, S; Bernard, RJ; Carpenter, P; Farhadfar, N; Ferraro, C; Tomlinson, K; Whiteside, S; Wiedl, C; Myers, K. Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2024; 30:534.e1-534.e13.

Rouce, R; Dolan, JG; Phillips, CL; Qayed, M; Pulsipher, MA; Vernau, LM; Galletta, TJ; Votaw, S; Llaurador Caraballo, G; Yang, H; Tesfaye, M; Lee, S; O'Sullivan, E; Grupp, SA. Impact of Current Manufacturing on Kymriah Real-World Effectiveness and Functional Persistence in Acute Lymphoblastic Leukemia (ALL) (KareALL): A Retrospective Study of Tisagenlecleucel (tisa-cel)-Treated Pediatric and Young Adult Patients (pts) with ALL. Blood. 2024; 144:7724.

Roy, B; Knapke, S; Pillay-Smiley, N; Zhang, X; Queen, K; Sisson, R. Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States. Pediatric Blood and Cancer. 2024; 71:e30725.

Rudman-Melnick, V; Adam, M; Stowers, K; Potter, A; Ma, Q; Chokshi, SM; Vanhoutte, D; Valiente-Alandi, I; Lindquist, DM; Nieman, ML; Kofron, JM; Chung, E; Park, JS; Potter, SS; Devarajan, P. Single-cell sequencing dissects the transcriptional identity of activated fibroblasts and identifies novel persistent distal tubular injury patterns in kidney fibrosis. Scientific Reports. 2024; 14:439.

Rudman-Melnick, V; Vanhoutte, D; Stowers, K; Sargent, M; Adam, M; Ma, Q; Perl, AK T; Miethke, AG; Burg, A; Shi, T; Hildeman, DA; Woodle, ES S; Kofron, JM; Devarajan, P. Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts. Scientific Reports. 2024; 14:29307.

Rumlow, Z; Almodallal, Y; Zimmerman, MB; Miner, R; Asbury, R; Knake, LA; Schmitz, A. The Impact of Diagnosis-Specific Plan Templates on Admission Note Writing Time: A Quality Improvement Initiative. Journal of Graduate Medical Education. 2024; 16:581-587.

Sabulski, A; Pommert, L. Eculizumab: Inhibiting C5 Earns a High Five in Prospective Pediatric, Multicenter, High-risk Transplant-associated Thrombotic Microangiopathy Study. 2024; 21.

Sabulski, DA; Langenberg, L; Luebbering, N; Libermann, TA; Dillon, ST; Koo, J; Myers, KC; Jodele, S; Davies, SM. Plasma Proteome Analyses Identify Predictors of Graft Rejection Prior to Stem Cell Infusion and Support Interferon-Mediated Ferroptosis As a Novel Mechanism of Graft Rejection. Transplantation and Cellular Therapy. 2024; 30:s4-s5.

Sadaf, A; Dong, M; Pfeiffer, A; Korpik, J; Kalfa, TA; Latham, T; Vinks, AA; Ware, RE; Quinn, CT. A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy. British Journal of Haematology. 2024; 205:1147-1158.

Sadaf, A; Dong, M; Pfeiffer, A; Latham, T; Kalfa, T; Vinks, AA; Ware, RE; Quinn, CT. A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects. Clinical Pharmacokinetics. 2024; 63:357-365.

Saraf, SL; Hagar, R; Idowu, M; Osunkwo, I; Cruz, K; Kuypers, FA; Brown, RC; Geib, J; Ribadeneira, M; Schroeder, P; Wu, E; Forsyth, S; Kelly, PF; Kalfa, TA; Telen, MJ. Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease. Blood Advances. 2024; 8:4459-4475.

Sarangdhar, M; O'Brien, E; VanCauwenbergh, B; Basu, M; Snyder, J; Leuenberger, G; Perentesis, JP. High-Throughput Drug Repurposing Identifies SN-38 As a Potent Inhibitor of AML with Synergistic Effects in Combination with PARP and BCL-2 Inhibitors for Treating KMT2A-Rearranged Leukemias. Blood. 2024; 144:2203.

Sarkar, N; Myers, KC; Lane, A; Davies, SM; Benoit, SW. Pre-transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients. Pediatric Blood and Cancer. 2024; 71:e30853.

Satty, AM; Klein, E; Mauguen, A; Kunvarjee, B; Boelens, JJ; Cancio, M; Curran, KJ; Kernan, NA; Prockop, SE; Scaradavou, A; Torok-Castanza, J; Mehta, PA; O’Reilly, RJ; Boulad, F. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML. Bone Marrow Transplantation. 2024; 59:23-33.

Schafer, ES; Rushing, T; Crews, KR; Annesley, C; Colace, SI; Kaiser, N; Pommert, L; Ramsey, LB; Sabnis, HS; Wong, K; Chi, YY; Bhojwani, D; Wayne, AS; Bernhardt, MB. Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium. Journal of the National Cancer Institute. 2024; 116:1721-1729.

Schmidt, AL; Kremp, M; Aratake, T; Cui, S; Lin, Y; Zhong, X; Lu, QR; Zhang, C; Qiu, M; Aberle, T; Wegner, M. The myelination-associated G protein-coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation. Glia. 2024; 72:1304-1318.

Schoettler, ML; Lehmann, L; Kao, PC; Chen, N; Jodele, S; Chonat, S; Williams, KM; London, WB; Duncan, C; Dandoy, C. Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood Advances. 2024; 8:1220-1233.

Schrenk, S; Bischoff, LJ; Boscolo, E. Protocol for three-dimensional whole-mount imaging of the vascular network in the intestinal muscle. Star Protocols. 2024; 5:103170.

Schuster, JE; Hamdan, L; Dulek, DE; Kitko, CL; Batarseh, E; Haddadin, Z; Stewart, LS; Stahl, A; Potter, M; Rahman, H; Munoz, FM; Danziger-Isakov, L; Spieker, AJ; Halasa, NB. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clinical Infectious Diseases. 2024; 78:217-226.

Schwede, M; Jahn, K; Kuipers, J; Miles, LA; Bowman, RL; Robinson, T; Furudate, K; Uryu, H; Tanaka, T; Sasaki, Y; Levine, R; Beerenwinkel, N; Takahashi, K; Majeti, R. Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia. 2024; 38:1501-1510.

Segbefia, C; Luchtman-Jones, L. Seeing haemoglobin SC: Challenging the misperceptions. British Journal of Haematology. 2024; 205:404-405.

Segbefia, CI; Smart, LR; Stuber, SE; Amissah-Arthur, KN; Dzefi-Tettey, K; Ekpale, P; Mensah, E; Lane, AC; Ghunney, W; Tagoe, LG; Oteng, A; Amoako, E; Latham, TS; Dei-Adomakoh, YA; Ware, RE. Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa. British Journal of Haematology. 2024; 205:2470-2480.

Sekyonda, Z; An, R; Goreke, U; Man, Y; Monchamp, K; Bode, A; Zhang, Q; El-Gammal, Y; Kityo, C; Kalfa, TA; Akkus, O; Gurkan, UA. Rapid measurement of hemoglobin-oxygen dissociation by leveraging Bohr effect and Soret band bathochromic shift. The Analyst. 2024; 149:2561-2572.

Setayesh, T; Chi, M; Oestreicher, Z; Sakabe, M; Mei, X; Vandenheuvel, K; Townes, TM; Hu, Y; Malik, P. A Novel Mouse Model of Hemoglobin-SC Disease: Bridging the Knowledge Gap in Sickle Cell Disease. Blood. 2024; 144:620.

Seu, K; Romano, L; Ntoumaziou, A; Stewart, M; Gardner, JC; Paulson, R; Zheng, Y; Kofron, M; Blanc, L; Salomonis, N; Kalfa, TA. Heterogeneity of the Erythromyeloblastic Island (EMBI) Niche during Baseline and Stress Erythropoiesis. Blood. 2024; 144:163.

Shadid, M; Shrestha, A; Malik, P. Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies. Editor, Ling C. PloS one. 2024; 19:e0306719.

Shanthikumar, S; Goldfarb, S; Abts, M; Barochia, A; Bergeron, A; Blinman, T; Bracken, J; Calvo, C; Casey, A; Charbek, E; Teusink-Cross, A; Towe, CT; Walkup, LL; Yanik, GA. Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2024; 210:262-280.

Shanthikumar, S; Gower, WA; Cooke, KR; Bergeron, A; Schultz, KR; Barochia, A; Tamae-Kakazu, M; Charbek, E; Reardon, EE; Calvo, C; Towe, CT; Yanik, GA; Iyer, NP; Goldfarb, SB. Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?. Transplantation and Cellular Therapy. 2024; 30:760-769.

Sheth, AI; Althoff, MJ; Tolison, H; Engel, K; Amaya, ML; Krug, AE; Young, TN; Minhajuddin, M; Pei, S; Patel, SB; Smith, CA; Pollyea, DA; Stevens, BM; Jordan, CT. Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium. Cancer Discovery. 2024; 14:1922-1939.

Shimamura, A; Myers, K; Andresen, F; Zhou, Y; Reed, H; Do, H; Weller, E. 1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION. Experimental Hematology. 2024; 137:104303.

Shimano, KA; Rothman, JA; Allen, SW; Castillo, P; de Jong, JL O; Dror, Y; Geddis, AE; Lau, BW; McGuinn, C; Narla, A; Myers, K; Gloude, NJ; Broglie, L; Boklan, J. Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations. Pediatric Blood and Cancer. 2024; 71:e31070.

Shimano, KA; Sasa, G; Broglie, L; Gloude, NJ; Myers, K; Nakano, TA; Sharathkumar, A; Rothman, JA; Pereda, MA; Overholt, K; de Jong, JL O; Castillo, P; Allen, SW; Boklan, J. Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations. Pediatric Blood and Cancer. 2024; 71:e31075.

Shook, LM; Crosby, LE; Farrell, CB; Nelson, SC. A health equity ECHO for clinicians of individuals with SCD. 2024; 1.

Shook, LM; Rosen, BL; Mara, CA; Mosley, C; Thompson, AA; Smith-Whitley, K; Schwartz, L; Barriteau, C; King, A; Oke, E; Jallow, F; Murphy, B; Crosby, L. Attitudes, Beliefs, and Intention to Receive a COVID-19 Vaccine for Pediatric Patients With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology. 2024; 46:e305-e312.

Shook, LM; Ware, RE. Screening for haemoglobin disorders: One size may not fit all. British Journal of Haematology. 2024; 204:26-28.

Shulman, DS; Klega, KS; Chen, N; Gohn, E; Henry, D; Choy, E; Cash, T; Schultz, KA P; Mascarenhas, L; Bagatell, R; Maese, LD; London, WB; DuBois, SG; Crompton, BD. Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study. Journal of Clinical Oncology. 2024; 42:11510.

Siefert, M; Rheiner, S; Ziady, A; Lin, S. 269 Modulating nucleolin trafficking can significantly enhance DNA nanoparticle-mediated gene expression in the lung. Journal of Cystic Fibrosis. 2024; 23:s143.

Siefert, ME; Skala, EJ; Potter, AS; Hayes, D; Ziady, A. (1358) Plasma and Bronchoalveolar Fluid Proteomes Identify Similar Pathways Associated with Allograft Dysfunction in Individual LTx Recipients with Different Underlying Conditions. The Journal of Heart and Lung Transplantation. 2024; 43:s625-s626.

Siegert, TF; Opoka, RO; Nakafeero, M; Carman, A; Mellencamp, KA; Latham, T; Hume, H; Lane, A; Ware, RE; Ssenkusu, JM; John, CC; Conroy, AL. Angiopoietin-2 is associated with sickle cell complications, including stroke risk, and decreases with hydroxyurea therapy. 2024; 1:100001.

Simkin, J; Aloysius, A; Adam, M; Safaee, F; Donahue, RR; Biswas, S; Lakhani, Z; Gensel, JC; Thybert, D; Potter, S; Seifert, AW. Tissue-resident macrophages specifically express Lactotransferrin and Vegfc during ear pinna regeneration in spiny mice. Developmental Cell. 2024; 59:496-516.e6.

Skala, E; Banerjee, R; Siefert, M; Dusa, C; Stevens, C; Hils, B; Bdaiwi, A; Hayes, D; Cleveland, Z; Ziady, A. 846 Plasma proteomics identifies changes in disease-associated pathways in subjects with CF bronchiectasis after elexacaftor/tezacaftor/ivacaftor initiation. Journal of Cystic Fibrosis. 2024; 23:s490.

Skala, EJ; Siefert, ME; Potter, AS; Sharma, N; Hayes, D; Ziady, AG. (610) Bronchoalveolar Lavage and Plasma Proteomes Identify Features of Disease That Segregate Lung Transplant Recipients with versus without Bronchiolitis Obliterans Syndrome. The Journal of Heart and Lung Transplantation. 2024; 43:s297.

Smart, LR; Ambrose, EE; Charles, M; McElhinney, K; Latham, TS; Stuber, SE; Ware, RE. Pharmacokinetic (PK)-Guided Dosing of Hydroxyurea for Tanzanian Children with Sickle Cell Anemia. Blood. 2024; 144:289.

Snyder, AJ; Campbell, KM; Lane, A; Mehta, PA; Myers, K; Davies, SM; Koo, J. Liver abnormalities are frequent and persistent in patients with Fanconi anemia. Blood Advances. 2024; 8:1427-1438.

Snyder, AJ; Miller, E; O'Conner, A; Campbell, KM; Mehta, PA; Myers, KC; Davies, SM; Koo, DJ. Frequent Fanconi Anemia-Associated Liver Abnormalities before and after HSCT. Transplantation and Cellular Therapy. 2024; 30:s291-s292.

Solomon, M; Song, B; Govindarajah, V; Good, S; Arasu, A; Hinton, EB; Thakkar, K; Bartram, J; Filippi, MD; Cancelas, JA; Salomonis, N; Grimes, HL; Reynaud, D. Slow cycling and durable Flt3+ progenitors contribute to hematopoiesis under native conditions. The Journal of Experimental Medicine. 2024; 221:e20231035.

Spears, K; Goodin, CS; Meyer, R; Kusnier, K; Haslam, D; Dandoy, DC E; Davies, SM; Badia, P. The Scrubbing Olympics. Transplantation and Cellular Therapy. 2024; 30:s69-s70.

Sprokkerieft, J; van der Beek, JN; Spreafico, F; Selle, B; Chowdhury, T; Graf, N; Verschuur, AC; Dandis, R; Bex, A; Geller, JI; Tytgat, GA M; van den Heuvel-Eibrink, MM. Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review. Critical Reviews in Oncology/Hematology. 2024; 204:104523.

Stepanchick, E; Wilson, A; Sulentic, AM; Choi, K; Hueneman, K; Starczynowski, DT; Chlon, TM. DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy. Leukemia. 2024; 38:1787-1798.

Stieglitz, E; Pommert, L. Risk-stratified Treatment for Pediatric Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia. 2024; 21.

Stiff, A; Fornerod, M; Kain, BN; Nicolet, D; Kelly, BJ; Miller, KE; Mrózek, K; Boateng, I; Bollas, A; Garfinkle, EA R; Salomonis, N; Grimes, HL; Mardis, ER; Eisfeld, AK. Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia. Nature Genetics. 2024; 56:2434-2446.

Strecker, L; Towe, C; Sabulski, DA; Langenberg, L; Libermann, TA; Dillon, ST; Gu, X; Davies, SM; Koo, DJ; Myers, KC. Proteomic Analysis of Bronchoalveolar Lavage Fluid from Children with Bronchiolitis Obliterans Syndrome Identifies Potential Treatment Strategies. Transplantation and Cellular Therapy. 2024; 30:s252-s253.

Takahashi, T; Lake, AJ; Wachter, F; Calderon, FA; Dandoy, C; Keating, AK. Effects of Total Body Irradiation on Hematopoietic Cell Transplantation Outcomes in Pediatric Acute Myeloid Leukemia with Prior Central Nervous System Involvement. Transplantation and Cellular Therapy. 2024; 30:812.e1-812.e11.

Tang, H; Shi, J; Zhang, S; Chen, Y; Xiong, T; Wang, X; Chen, Z; Dai, Z; Yao, Z; Lu, Q. Specific Associations in the Alpha Frequency Between the Subcomponents of Rumination and the Subsystems of the Default Mode Network Among Bipolar I Disorder Patients. Brain Connectivity. 2024; 14:542-549.

Tang, H; Xia, Y; Hua, L; Dai, Z; Wang, X; Yao, Z; Lu, Q. Electrophysiological predictors of early response to antidepressants in major depressive disorder. Journal of Affective Disorders. 2024; 365:509-517.

Thorman, AW; Reigle, J; Chutipongtanate, S; Yang, J; Shamsaei, B; Pilarczyk, M; Fazel-Najafabadi, M; Adamczak, R; Kouril, M; Bhatnagar, S; Hildeman, DA; Medvedovic, M; Herr, AB; Meller, J. Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking. Science Advances. 2024; 10:eadj3010.

Towe, C; Patti, J; Stevens, CA; Myers, KC; Cook, E; Cooper, R; Abts, MF; Baker, KS; Ballard, S; Urrego, FA; Melton, A; Noori, S; Woods, JC; Davies, SM; Goldfarb, SB. Feasibility of Home Spirometry for Early Identification of Pulmonary Dysfunction after HSCT in the Transpire Research Study. Transplantation and Cellular Therapy. 2024; 30:s138-s139.

Uible, EE; Hueneman, K; Bolanos, LC; Choi, K; Seibel, W; Starczynowski, D. The Zymogen Form of Caspase-1 Is Required to Finetune Excessive Cell-Intrinsic Inflammation in Myelodysplastic Syndromes. Blood. 2024; 144:4572.

Unaka, N; Kahn, RS; Spitznagel, T; Henize, AW; Carlson, D; Michael, J; Quinonez, E; Anderson, J; Beck, AF; Alexander, CE; Lamy, M; Power-Hays, A; Quinn, CT; Niss, OY. An Institutional Approach to Equity and Improvement in Child Health Outcomes. Pediatrics. 2024; 154:e2023064994.

Uschner, D; Sverdlov, O; Carter, K; Chipman, J; Kuznetsova, O; Renteria, J; Lane, A; Barker, C; Geller, N; Proschan, M; Posch, M; Tarima, S; Bretz, F; Rosenberger, WF. Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions. Statistics in Biopharmaceutical Research. 2024; 16:405-413.

Uschner, D; Sverdlov, O; Carter, K; Chipman, JJ; Kuznetsova, O; Renteria, J; Lane, A; Barker, C; Geller, NL; Proschan, M; Posch, M; Tarima, S; Bretz, F; Rosenberger, WF. Rejoinder. Statistics in Biopharmaceutical Research. 2024; 16:425-427.

Ustun, C; Chen, M; Kim, S; Auletta, JJ; Batista, MV; Battiwalla, M; Cerny, J; Gowda, L; Hill, JA; Liu, H; Dandoy, CE; Perales, MA; Riches, M; Papanicolaou, GA. Post-transplantation cyclophosphamide is associated with increased bacterial infections. Bone Marrow Transplantation. 2024; 59:76-84.

Uyoga, S; Muteti, M; Makale, J; Mochamah, G; Ware, RE; Williams, TN. RED Blood Cell Alloimmunization in Sickle Cell Anaemia Patients in Kilifi, Kenya. Blood. 2024; 144:5602.

Vandenbroeke, T; Gloor, C; Wingfield, T; Leite, C; Carr, K; Turner, C; Ngamsuntikul, S; Sutor, L; Compton, F; Nestheide, S; Rugg, N; Cancelas, JA; Dumont, LJ. In vitro quality parameters of whole blood-derived platelets pooled using two different platelet pooling sets and stored up to 7 days are similar. Transfusion. 2024; 64:132-140.

Vasu, S; Bejanyan, N; Miller, EG; Elder, P; Zhao, Q; Davies, SM; Hahn, TE. TA-TMA Is Frequent, but Not All TA-TMA Is Actionable in Adult Allogeneic HCT Patients: A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy. 2024; 30:s19.

Verkamp, B; Jodele, S; Marsh, RA; Sabulski, DA; Davies, SM; Jordan, MB. Emapalumab Therapy Prior to Hematopoietic Stem Cell Transplant Is Associated with Improved Long-Term Chimerism and Event-Free Survival in Pediatric Patients with Hemophagocytic Lymphohistiocytosis. Transplantation and Cellular Therapy. 2024; 30:s93.

Verkamp, B; Jodele, S; Sabulski, A; Marsh, R; Kieser, P; Jordan, MB. Emapalumab therapy for hemophagocytic lymphohistiocytosis before reduced-intensity transplantation improves chimerism. Blood. 2024; 144:2625-2636.

Vicente-Muñoz, S; Davis, JC; Lane, A; Lane, AN; Waltz, SE; Wells, SI. Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes. Frontiers in Oncology. 2024; 14:1382986.

Waarts, MR; Mowla, S; Boileau, M; Martinez Benitez, AR; Sango, J; Bagish, M; Fernández-Maestre, I; Shan, Y; Eisman, SE; Park, YC; Butler, JM; Cai, SF; Bowman, RL; Levine, RL. CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant Cells. Cancer Discovery. 2024; 14:1860-1878.

Walder, TA; Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Rare BK polyomavirus subtype III detected in hematopoietic cell transplant recipient. Editor, Matthijnssens J. Microbiology Resource Announcements. 2024; 13:e0067624.

Wang, C; Sun, B; Wu, K; Farmer, JR; Ujhazi, B; Geier, CB; Gordon, S; Westermann-Clark, E; Savic, S; Secord, E; Wang, W; Wang, JY; Wang, X; Walter, JE. Clinical, immunological features, treatments, and outcomes of autoimmune hemolytic anemia in patients with RAG deficiency. Blood Advances. 2024; 8:603-607.

Wang, D; Zhang, F; Yang, C; George, A; Veltri, A; Thakar, M; Verbsky, J; Myers, K; Kee, BL; Rao, S; Bresnick, EH; Malarkannan, S. GATA2-TGF-b1-TAL1 Axis Is Essential for Human NK Cell Development and Function. Blood. 2024; 144:5398.

Wang, J; Yang, L; Du, Y; Wang, J; Weng, Q; Liu, X; Nicholson, E; Xin, M; Lu, QR. BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination. The Journal of Cell Biology. 2024; 223:e202310143.

Wang, X; Zhang, H; Dong, L; Zhang, X; Xue, M; Ren, L; Bi, H; Ghoda, LY; Wunderlich, M; Mulloy, JC; Heisterkamp, N; Kortylewski, M; Chen, J; Su, R. Mitochondrial RNA Methylation By METTL17 Rewires Metabolism and Regulates Retrograde Mitochondrial-Nuclear Communication in AML. Blood. 2024; 144:625.

Wang, YZ M; Huber, JF; Flesch, L; Demmel, K; Lane, A; Beebe, DW; Crosby, LE; Hogenesch, JB; Smith, DF; Davies, SM; Dandoy, CE. Trajectory of Sleep, Depression, and Quality of Life in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2024; 30:632.e1-632.e5.

Wang, YZ M; Kaj-Carbaidwala, B; Lane, A; Agarwal, S; Beier, F; Bertuch, A; Borovsky, KA; Brennan, SK; Calado, RT; Catto, LF B; Simonetto, DA; Ziegler, DS; Miethke, AG; Myers, KC. Liver disease and transplantation in telomere biology disorders: An international multicenter cohort. Hepatology Communications. 2024; 8:e0462.

Ware, RE; Quinn, CT. The bold promise of gene therapy for sickle cell disease. British Journal of Haematology. 2024; 204:381-382.

Watanabe, H; Rana, M; Son, M; Chiu, PY; Fei-Bloom, Y; Choi, K; Diamond, B; Sherry, B. Single cell RNA-seq reveals cellular and transcriptional heterogeneity in the splenic CD11b+Ly6Chigh monocyte population expanded in sepsis-surviving mice. Molecular medicine (Cambridge, Mass.). 2024; 30:202.

Wei, J; Li, W; Zhang, P; Guo, F; Liu, M. Current trends in sensitizing immune checkpoint inhibitors for cancer treatment. Molecular Cancer. 2024; 23:279.

Williams, TN; Mochamah, G; Uyoga, S; Nyutu, G; Latham, TS; Backeljauw, P; Ware, RE; Tomlinson, GA. Growth Curves for Children Living with Sickle Cell Anemia in Kilifi County, Kenya, Do Not Follow Who Curves for Normal Children. Blood. 2024; 144:5315.

Wiseman, MT; Ebert, JJ; Augsburger, JJ; Di Nicola, M; Correa, ZM; Geller, JI; Williams, BK. Second Primary Malignant Neoplasms in Survivors of Retinoblastoma in a Single Ocular Oncology Practice. Clinical Ophthalmology. 2024; 18:3103-3109.

Wright, EN; Billups, C; Li, Y; Rush, S; Salloum, R; de Blank, P. MDB-100. RETROSPECTIVE ANALYSIS OF CUMULATIVE DOSING OF CHEMOTHERAPY AGENTS AND THE EFFECT ON SURVIVAL IN PATIENTS WITH AVERAGE RISK MEDULLOBLASTOMA TREATED ON CHILDRENS ONCOLOGY GROUP STUDY ACNS0331. Neuro-Oncology. 2024; 26:0.

Wright-Nadkarni, ML; Moscato, EL; Stanek, JR; Schaefer, MR; Gerhardt, CA; Ashley, DM; Baxter, PA; Chi, SN; Dorris, K; Fisher, MJ; Murala, M; Mikael, L; Fouladi, M; Lazow, MA. QOL-38. PSYCHOSOCIAL OUTCOMES OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG) –PROSPECTIVE, LONGITUDINAL PROMIS ASSESSMENTS OF PATIENTS ENROLLED ON CONNECT PHASE I CLINICAL TRIALS. Neuro-Oncology. 2024; 26:0.

Wu, J; Ratner, N. Neurofibromatosis Type I: Preclinical Modeling. The RASopathies. : Springer Nature; Springer Nature; 2024.

Wu, PV; Fish, M; Hazard, FK; Zhu, C; Vennam, S; Walton, H; Przybyl, J; Morri, M; Neff, N; West, RB; Nusse, R. Abstract B024: Single cell transcriptomics and patient-derived tumoroids reveal that hepatobiliary lineage programs cooperate with Wnt pathway mutations to drive cell proliferation in hepatoblastoma. Cancer Research. 2024; 84:b024.

Wu, PV; Fish, M; Hazard, FK; Zhu, C; Vennam, S; Walton, H; Wagh, D; Coller, J; Przybyl, J; Morri, M; Neff, N; West, RB; Nusse, R. A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma. Nature Communications. 2024; 15:10007.

Wu, Q; Zhang, J; Kumar, S; Shen, S; Kincaid, M; Johnson, CB; Zhang, YS; Turcotte, R; Alt, C; Ito, K; Ito, K; Way, SS; Kofron, JM; Lucas, D. Resilient anatomy and local plasticity of naive and stress haematopoiesis. Nature. 2024; 627:839-846.

Xin, DE; Liao, Y; Rao, R; Ogurek, S; Sengupta, S; Xin, M; Bayat, AE; Seibel, WL; Graham, RT; Koschmann, C; Lu, QR. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201. Neuro-Oncology. 2024; 26:735-748.

Xin, E; Zhong, X; Huang, C; Lu, R. CSIG-26. TARGETING EPIGENETIC DYSREGULATION AND ADAPTIVE RESISTANCE MECHANISMS IN DIPG/DMG. Neuro-Oncology. 2024; 26:viii69.

Xu, J; Fei, P; Simon, DW; Morowitz, MJ; Mehta, PA; Du, W. Crosstalk between DNA Damage Repair and Metabolic Regulation in Hematopoietic Stem Cells. Cells. 2024; 13:733.

Xu, X; Denton, J; Wu, Y; Liu, J; Guan, Q; Dawson, DB; Bleesing, J; Zhang, W. Genetic Testing in Patients with Autoimmune Lymphoproliferative Syndrome: Experience of 802 Patients at Cincinnati Children's Hospital Medical Center. Journal of Clinical Immunology. 2024; 44:166.

Yang, J; Zheng, Y; Guo, F. Autism-related CHD8 is required for maintaining Treg cell fitness. Journal of immunology (Baltimore, Md. : 1950). 2024; 212:1217_5681.

Yang, Y; Huang, Q; Cheng, M; Deng, L; Liu, X; Zheng, X; Wei, J; Lei, Y; Li, X; Guo, F; Deng, Y; Zheng, Y; Bi, F; Wang, G; Liu, M. Efficacy and advantage of immunotherapy for melanoma via intramuscular co-expression of plasmid-encoded PD-1 and CTLA-4 scFvs. AMERICAN JOURNAL OF CANCER RESEARCH. 2024; 14:2626-2642.

Zarnegar-Lumley, S; Pommert, L. Room To Grow: Bosutinib Approved for Newly Diagnosed or Relapsed/Intolerant Pediatric Chronic Myeloid Leukemia. 2024; 21.

Zhang, D; Tang, W; Niu, H; Tse, W; Ruan, HB; Dolznig, H; Knösel, T; Karl-Heinz, F; Themanns, M; Wang, J; Kenner, L; Moriggl, R; Zheng, Y; Han, X. Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia. Genes and Diseases. 2024; 11:413-429.

Zhang, Q; Du, Y; Bao, C; Hua, L; Yan, R; Dai, Z; Xia, Y; Zou, H; He, C; Sun, H; Lu, Q; Yao, Z. Aberrant high-beta band functional connectivity during reward processing in melancholic major depressive disorder: An MEG study. NeuroImage-Clinical. 2024; 43:103666.

Zhang, Y; Wang, X; Zhu, R; Sakabe, M; Chowdhury, D; Li, Z; Chen, J; Huang, W; Xin, M; Fan, G. Abstract 4118360: Lipocalin10 is Critical for Macrophage Efferocytosis to Repair Myocardial Ischemia/Reperfusion Injury. Circulation. 2024; 150:a4118360.

Zheng, Y. Conditioning for alloengraftment in FA. Blood. 2024; 143:2120-2122.

Zinter, MS; Brazauskas, R; Strom, J; Chen, S; Bo-Subait, S; Sharma, A; Beitinjaneh, A; Dimitrova, D; Guilcher, G; Preussler, J; Winestone, L; Duncan, C; Phelan, R; Dvorak, CC. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients. Blood Advances. 2024; 8:1002-1017.